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IABSTRACT
The biosynthetic pathway which leads, in Cephalo-
sporium acremonium, to the production of the
commercially important {)-lactam antibiotic Cephalo-
sporin C (CPC) has been the subject of extensive
biochemical studies and is now well character-
ized. In contrast, genetic analysis in this
organism was limited until the application of
protoplast fusion techniques facilitated para-
sexual analys is and allowed a genet ic map to
be established. (Hamlyn 1982; Hamlyn et al
1985) . Subsequently, work leading to our under-
standing of the genetic basis of the CPC bio-
synthetic pathway in C. acremonium began. (Perez-
Martinez 1984; Perez-Martinez and Peberdy in
preparation) .
The studies described here were aimed at extending
this understanding to a point at which individual
genes implicated in the pathway could be identified
and positioned on the linkage map. A programme
of mutagenesis resulted in the production of
a number of 'blocked' mutant strains of C. acremonium
which were phenotypically
par t LcuLar steps of the CPC
The segregation of several
unable to carry out
biosynthetic pathway.
of these mutations
II
relative to other genetic markers was examined.
Crosses designed to detect complementation
between mutations resulting in a 'blocked' pheno-
type were carried out and involved strains produced
in other laboratories in addition to those charac-
terized during this work. Complementation was
shown between two mutations which apparently
affected the same step in CPL biosynthesis (the
conversion of pe~icillin N into deacetoxycephalo-
sporin C) and evidence for the linkage of one
of the mutations (cnp-6) to a mutation resulting
in a requirement for inositol was obtained.
During the course of the complementation studies,
it was noted that the haploid and heterozygous
products obtained following ~. acremonium protoplast
fusion crosses did not always behave in the typical
manner described previously. (Hamlyn 1984).
The
,
persistent heterogeneity of these fusion
products and the possible implications of this
are discussed.
To my
Parents
CHAPTER 1
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INTRODUCTION
Cephalosporium acremonium
and the B-lactam antibiotic Cephalosporin C.
Cephalosporium acremonium (Acremonium strictum
Gams) is a filamentous fungus of considerable
importance being the organism used in the industrial
productiop of the ~-lact~m antibiotic cephalosporin C
(CPC) which forms the base for the chemical
derivitization of a range of antibacterial agents.
The organism belongs to the class Hyphomycetes of the
Fungi Imperfecti and reproduces vegetatively by the
production of ellipsoidal or spherical conidia. C.
acremonium was transferred into the genus Acremonium
following the taxonomical studies of Gams (1971) who
also described further members of the group. The
taxonomic descriptions of, and relationships between,
many of these strains have been reviewed by Onions
and Brady (1987). Some Cephalosporium species have
been shown to have teleomorphic stages which have
been classified into different orders of Ascomycetes.
Both the anamorphic and teleomorphic stages of a
number of these species produce compounds with
antibacterial activity (Roberts 1952; Kavanagh et al
1958a.; Nara and Johnson 1959; Elander etal 1960;
Cole a~d Rolinson 1961; Higgens et al 1974; Kitano et
-2-
al 1975). For example, the teleomorphic stage of
Cephalosporium salmosynnematum which produces the
antibiotic synnematin B has been classified into the
genus Emer.icellopsis of the order Eurotiales
(Groslags and Swift 1957). Species of the other
related genera to Cephalosporium including
Paecilomyces have also been observed to produce
antibiotics related to others produced by
C acremonium as have several species of Streptomyces
(Heischman et al 1960: Pisano et al 1960: Kitano et
al 1974, 1975, Kitano 1983).
Over past years a considerable effort has been
directed towards developing an unders tanding of the
mechanisms underlying the biosynthesis of CPC. A
biosynthetic pathway has been established and a
number of regulatory effects have been identified.
These aspects together with work on the genetic basis
of CPC production will be described. In comparison
to studies on penicillin production by Aspergillus
nidulans and Penicillium chrysogenum genetic studies
on CPC biosynthesis are limited due to problems
associated with the establishment of an amenable
laboratory system for obtaining genetic recombination
in C. acremonium.
1.1 Antibiotic production by C.:acremonium.
-3-
The C. acremonium strains used in the production
of cephalosporin C based J3-lactam antibiotics have
all been obtained by mutagenesis and selection
programmes from the original C. acremonium strain
isolated by Brotzu (1948). The Brotzu isolate
produced a number of antibiotic agents including five
related compounds classified as the cephalosporin P
group. These are acidic molecules, extractable in
organic solvents, active against gram positive
bacteria and resembling helvolic acid produced by
Aspergillus fumigatus (Burton and Abraham 1951,
Crawford et al 1952). However, most early interest
centred on cephalosporin N which proved active
against a wider spectrum of micro-organisms than did
the P group of compounds. Cephalosporin N is
hydrophobic and sensitive to inactivation by
penicillinase
,
enzymes. Structural analysis led to
its classification as a penicillin having the B-
lactam-thiazolidine ring structure shown in Fig.
1.1 (Burton and Abraham 1951: Crawford et al 1952:
Abraham at 1953 and 1954: Newton and Abraham 1953 and
1954) Cephalosporin N, later renamed penicillin N
(Pen N) is recognised as identical to synnematin B
produced by Cephalosporium salmosynnematum (Olson et
al'1952: Abraham et al 1955).
The ,presence of CPC as a contaminant in a crude
-4-
Fig. 1.1 The chemical structures of penicillin N
and cephalosporin c.
Penicillin N
H N
2 ><D) H(L) S CH
ClI--(CH2)3--e0:tL~ 3
HCOC CH3
r-N (D) COOH
Cephalosporin e
eOGH
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preparation of Pen N was reported by Newton and
Abraham (1955). Although this compound had a lower
activity than Pen N against most micro-organisms
tested, it was sensitive to penicillinase
inactivation. On acid hydrolysis CPC yielded 7-
aminocephalosporanic acid plus D-d-amino acid. The
~-lactam dihydrothiazine ring structure shown in Fig
1.1 was consequently proposed for it (Abraham and
Newton 1956 and 1961: Loder et al 1961)
1.2 Development of strains for the industrial
production of CPC.
Strain M8650 which had been derived from the
original CPC produc ing
al 1966) was chosen
programmes of strain
Brotzu isolate (Stauffer et
as the progenitor strain for
improvement initiated from the
1950's onwards designed to produce strains capable of
increased CPC production with growth characteristics
suitable for industrial use. Spores were treated
with a variety of physical and chemical mutagens and
large numbers of survivors were screened for any
increase in capability to produce CPC. As improved
strains were isolated the fermentation conditions
being used were gradually tailored to further
Of theoptimise the l~vel of production obtained.
mutagenic agents used, ultraviolet radiation was
-6-
shewn to. be the rnost effective in preducing raised
ti tre strains. Hewever, since regiens of genetic
leci may exhibit differential sensitivities to.
mutagens at least ene ef the strain imprevement
pregrammes used a cembinatien ef chemical and
physical treatments. Thus mutagenesis was carried
eut in reunds switching between the use ef N-methyl-
N-nitre-N-nitreseguanidine, nitreus acid and
ultravielet radiatien (Elander et al 1976). Strains
subjected to. multiple reunds ef ultravielet
mutagenesis were feund to. beceme increasingly
sensitive to. the effects ef ultravielet light.
After mutagenesis surviving pepulatiens had a
decreased average ability to. preduce CPC, hewever,
there was also. an increase in the variability ef
titre preduced. Therefere it was pessible to.select
strains with increased preductien capacities in a
stepwise manner 'threugh many r-ounds of mutagenesis
(Brewn and Elander 1966). During strain selectien
pregrammes it was no t ed that strains with impreved
GPC yields also. tended to. shew altered grewth
characteristics. The grewth rate appeared to. have
been lewered, giving a decrease in celeny diameter en
plates and a decrease in vegetative develepment
during fermentatien. The ability to. sperulate was
lowered and a tendency tewards arthrespere forma t i.on
was seen (Elander 1974). As the antibietic titre ef
-7-
strains increased it was found that the probability
of obtaining even higher producing strains after
mutagenesis decreased. This necessitated the
improvement of the screening procedures being used to
detect mutants with raised titres. At first the
isolates obtained were screened for antibiotic
production in shake flask fermentations but this
limited the number which could be examined at anyone
time. Therefore a method of assaying colonies grown
on agar plugs previously used for screening A.
nidulans (Ditchburn et al 1974) was adapted for use
with ~ acremonium (Trilli et al1978). Antibiotic
production was monitored by placing the plugs on agar
seeded with bacterial strains sensitive to the
antibiotic in question and measuring the zones of
inhibition produced on the plates. The relative
production of antibiotic on plugs was found to
correlate closely enough with production in shake
flasks in order to make this method acceptable for
use as a primary screen for raised titre mutants
(Trilli et al 1978). Modifications of this method
and screening techniques involving the calculation of
a potency index, measured as the diameter of the
Colony divided by the diameter of the colony plus the
inhibition. zone produced by it, have been developed
(Ball and McGonagle 1978: Freysoldt et al 1986).
In a review of mutagenesis in C. acremonium
-8-
Elander et al (1976) reported that auxotrophic and
morphologically abnormal strains derived from
mutagenised populations were frequently found to have
reduced antibiotic titres. Such observations led to
the proposal of a set of indirect selection
parameters by which isolates could be recovered, on
the basis of various characteristics not related
specifically to CPC production for titre testing with
an increased probability that they would be improved
producers. These procedures are discussed in detail
by Chang and Elander (1979) and also include the
selection of mutants resistant to analogues of the
amino acid precursors of the antibiotic. These
mutants fall into two phenotypic classes those which
may have the capacity to over-produce the precursors
and those with altered permeability characteristics.
Auxotrophic mutants obtained during the strain
improvement programme were also reported occasionally
to yield raised titre strains on reversion to
prototrophy. Thus by observing the properties of
colonies surviving muta- genesis for characters other
than titre it might be possible to reduce the number
which must be assayed before a strain with improved
titre is obtained. These and other strategies used
to improve the production of secondary metabolites
have been revie~ed by Calam (1970), Demain (1973) and
Elander. (1978). With the use of such strain
-9-
improvement programmes the titre of the M8650
progeni tor strain has been increased considerably.
The application of parasexual genetics to C.
acremonium has also led to attempts to increase CPC
titre by the use of breeding methods and these will
be discussed in the following sections.
1.3 Genetic Studies
Originally
industrially
the genetic manipulation of
important fungi was based on the
empirical methods of mutagenesis and strain selection
as discussed previously. There has, more recently,
been considerable interest in the possibility of
improving the performance of ~-lactam producing fungi
by the use both of planned breeding schemes and the
techniques of molecular biology. Improvements which
might be sought co~ld relate either to an increase in
titre or to the production of cultures with improved
growth characteristics. The application of these
approaches was delayed in C.
lack of amenable systems
acremonium due to the
for achieving genetic
recombination in the laboratory. However, the
establishment and use of methods based on para-
sexuality for achieving recombination firstly, in A.
nidUlans (Pontecorvo and Roper 1952: Roper 1952:
Roper and Pritchard 1955: Pontecorvo et al 1953:
-10-
Forbes 1959)in which they were used alongside methods
based on the sexual cycle of this organism and then
in P. chrysogenum (Pontecorvo and Sermonti 1953 and
1954, Sermonti 1954, 1956, 1957 and 1961) have
allowed the study of the genetics of penicillin
production in these fungi to develop. The possible
exploitation of the understanding gained from these
studies has been discussed by Ball (1978 and 1980)
and Rowlands (1983).
Parasexual genetic mechanisms are those by which
genet:i,c recombination may occur without the
invOlvement of a standard sexual cycle. In the
parasexual cycle hyphal anastomosis leads to the
mixing of nuclei of two haploid strains in a common
cytoplasm, thus forming an area of heterokaryotic
growth. Nuclear fusion within such a heterokaryon
results in the formation of a clone of diploid
somatic cells which divide mitotically. Haploid
segregants are eventually obtained from the diploid
as a consequence of a lack of complete stability.
Haploidisation occurs as chromosomes are sequentially
lost as a result of mitotic nondisjunction events.
This leads via a range of aneuploid states to the
formation of haploid segregants often detectable as
sectors growing out from the diploid.
Haploi~isation ~s random to the extent that for each
chromosqme either parental homologue may be lost at a
-11-
given nondisjunctional event. Therefore all the
possible combinations of parental chromosomes should
be detectable amongst the haploid segregants obtained
from a diploid. As this process involves the
redistribution of whole chromosomes, alleles linked
together in one parent of a cross remain associated
during segregation whilst alleles of unlinked genes
show independent segregation. Therefore an
examination of the segregation patterns amongst the
progeny of a parasexual cross allows the
establishment of linkage relationships. Mitotic
recombination i.e. the recombination of genetic
material between non-sister chromatids, may occur
either before or during the process of haploidisation
and lead to the recovery of segregants recombinant
for genes positioned on the same linkage group and in
some cases allows for the ordering of markers within
linkage groups.
Pontecorvo (1956) estimated that unlike haploid
nuclei in a heterokaryon fuse at
range of 1 in 106 to 1 in
frequencies in the
107 and that the
frequencies of haploidisation and mitotic crossing
over were of the order of 1 in 1000 and 1 in 500
respectively. Variations on the basic pattern of
para-sexuality have been demonstrated in many fungi
(for review see eaten 1981) with the timing and
stability of the different stages involved and the
-12-
frequency with which nuclear fusion and mitotic
recombination occur differing according to the fungus
being studied.
A limited investigation into the genetics of CPC
production has been carried out in a teleomorphic
stage of Cephalosporium ~. belonging to the genus
Emericellopsis (Fantini and Olive 1960).
the majority of work has concentrated on the
However
investigation of the genetics of the imperfect C.
acremonium. Early attempts to establish parasexual
crosses in C. acremonium were largely disappointing.
The isolation of a stable diploid was described by
Nuesch et al (1973). Hyphal cells of this strain
were shown to be uninucleate but possessed nuclei
approximately twice the size of those seen in haploid
strains. Treatment of this putative diploid with
agents known to induce mitotic segregation led to the
isolation of hap10id segregants with recombinant
phenotypes suggesting that parasexual genetic
analysis was .in fact possible in C. acremonium.
However, Elander et al (1974) and Elander et al
(1974) reported unsuccessful attempts at constructing
crosses by hyphal anastomoses and noted that it was
difficult to obtain the formation of heterokaryons
and diploids. This was thought to be due to the
predominantly uninucleate nature of C. acremonium
cells and the lack of nuclear migration which occurs
-13-
between them. Some recombination was seen in
crosses between auxotrophs derived from raised titre
lines. However, no clear evidence for the existence
of diploids was found and the resulting recombinants
were slow growing, had a low capacity for CPC
production and were unstable in culture. Hamlyn and
Ball (1979) reported the isolation of a number of
stable prototrophic colonies following a cross, which
were presumed to be haploid recombinants and of two
uns table prototrophs which gave rise to a limited
spectrum of auxotrophic segregants. However, such
resul ts were obtained from only ten out of forty
crosses carried out and were therefore not particularly
promising.
The technique of protoplast fusion has more
recently been applied in order to bypass the
difficul ties found in establishing heterokaryon and
diploid states Il.n this organism. Following
protoplast isolation and fusion, nuclear fusion could
be observed in up to 1% of the treated protoplasts
(Hamlyn and Ball 1979). Thus a system of parasexual
analysis became feasible in C. acremonium.
Regeneration and reversion of fused protoplasts
yielded two types of progeny: stable and unstable.
The stable prototrophs and recombinant auxotrophs
were thouqh t to be haploid products obtained by the
rapid segregation of a transient diploid stage.
-14-
This led to the adoption of a method for the direct
recovery of haploid recombinants by the plating of
fused protoplasts directly onto selective media which
prevented the growth of parental types but allowed
the recovery of a range of recombinants. Unstable
heterozygous colonies were also found; these
segregated spontaneously to give haploid progeny with
recombinant phenotypes. This work gave further
support to the view that c. acremonium diploid nuclei
may be unstable and showed that diploidization is
frequently followed by the rapid segregation of
chromosomes. The analysis of crosses between
strains carrying auxotrophic and drug resistance
markers has led to the establishment of a linkage map
for c. acremonium (Hamlyn 1982; Hamlyn et al 1985;
Perez-Martinez and Peberdy 1987), and subsequent work
has examined aspects of the inheritance of antibiotic
production in thfs fungus. The association of
factors affecting Pen Nand CPC production with
linkage groups VIII and VI respectively has been
shown, Fig. 1.2 (Perez-Martinez 1984). The possible
usefulness of protoplast fusion as a technique to
improve c. acremonium strains for ~-lactam production
was demonstrated by Hamlyn and Ball (1979) in a cross
between two strains,
characteristics, the
phenotype. Amongst
one with favourable growth
other with a raised titre
the progeny obtained at least
-15-
Fig. 1..2 Linkage map for C. acremonium.
Linkage group Markers
leu-l
I
roet-l pyt-A
II
III
red-1
I
ino-1
I
5.6 12.9
arg-2
IV
arg-l
V
VI
cep-l
I
azu-l
I
lys-l
I
4.3
roor-l
VII
VIII
ane-5
I • ben-lI
pen-l
I
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one isolate had definitely improved production
characteristics, giving rise to a yield of antibiotic
at least 40% greater than that of the highest titre
parent and also showing an improved growth rate and
better sporulation. Minuth and Esser (1983) have
also suggested that parasexual genetics may be of use
in strain improvement and reported the transfer of
genetic material during interspecific crosses between
Cephalosporium ~. and intergeneric crosses between
Cephalosporium ~.and Emericello.psis ~.
However transfer of genes other than those used as
markers during protoplast fusion was rare.
It may be anticipated that the methods of
J
recombinant DNA technology will be increasingly
involved in both the study and the improvement of
commercially important micro-organisms such as C.
acremonium. The development of transformation
systems in A. nidulans (Ballance et al 1983: Tilburn
et al 1983: Yelton et al 1984: John and Peberdy 1984)
and Neurospora crassa (Case et al 1978 Schweizer et
al 1981: Akins and Lambowitz 1985) and the
development of suitable cloning vectors for use with
these fungi (Hughes et al 1983: Stohl and Lambowitz
1983: Ballance and Turner 1985: Vollmer and Yanofsky
1986), some four years ago paved the way for the use
of .thes-etechniques in several fungi where formal
genetic studies are less well developed. In 1984
-17-
the first report of transformation for C acremonium
was described, in which resistance to hygromycin or
G418 is used as a dominant selectable marker for the
selection of transformants (Queener et al 1984;
Penlava et al 1986; Skatrud et al 1987; Isogai et al
1987). More recently transformation of P.
chrysogenum has also been reported (Cantorel et al
1987; Skatrud et al 1987; Stahl et al 1987).
Previously the existence of a native plasmid in C.
acremonium has been reported (Minuth et al 1982;
Esser et al 1983). However, this did not have the
potential for development as a transformation vector.
As in other species, attempts have been made to
isolate DNA fragments which would promote
transformation, these involve components of the
mitochondrial genome (Minuth et al 1982) and in one
study a 1.9kb fragment (Tudzynski and Esser 1982;
Skatrud and Queener 1984; Oeser et al 1986) has been
added as a construct to a transformation vector for
~ acremonium(Queener et al 1984). The isolation of
the C. acremonium DNA sequence encoding the enzyme
isopenicillin N synthetase involved early in the CPC
biosynthetic pathway has been reported (Samson et al
1985; Harford et al 1986) Expression of this
sequence in ~. coli (Samson et al 1985) led to the
proguction of a protein which in crude cell extracts,
catalysed the conversion of LLD-ACV tripeptide
-18-
into a penicillinase sensitive compound having
properties consistent with isopenicillin N. Genes
encoding isopenicillin N synthetase have also been
isolated from P. chrysogenum (Carr et al 1986) and
from Streptomyces clavuligerus (Jensen et al 1987).
The predicted amino acid sequence derived from the S
clavuligerus isopenicillin N synthetase gene sequence
has been reported to show approximately 40% homology
to the sequence of the enzyme from C. acremonium
however, the degree of homology between the
respective nucleotide sequences is lower. In P.
chrysogenum the isopenicillin N synthetase gene
sequence shows approximately 74% homology to the f.:_
acremonium gene and the amino acid sequence predicted
from this is approximately 73%. homologous to that
predicted in C. acremonium (Carr et al 1986).
,
1.3.1 Genetic studies of ~-lactam·production in A.
nidulans and ?~ chrysogenum.
In comparison to the limited study of the genetic
bases of CPC biosynthes is in C. acremonium (Ball
1984: Perez-Martinez 1984) and Emericell~psis species
(Fantini and Olive 1960; Fantini 1962) investigations
into penicillin production in A. nidulans and P.
chrysoge-num (Ball 1973, 1984 ; MacDonald ·1983;
MacDonald and Holt 1976) have been more detailed and
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may sugges t approaches which could be of use in
developing an understanding of CPC production at a
genetical level.
A. nidulans was chosen as a model system since
although producing only low levels of penicillin,
extensive studies have been carried out on this
organism making it a well documented system.
Penicillin production was established to be under
nuclear control (MacDonald et al 1963 a and bi
Merrick and Caten 1975) and subsequently mutations
affecting penicillin titre have been classified into
at least seven complementation groups and assigned to
linkage groups (Table 1.1). Four groups npe A,
npe B, npe C and npe D were identified following the
study of mutations reducing titre to below ten
percent of the progenitor strain and the remaining
three following examination of raised titre mutants.
Interes tingly when' mutants with low titre were
examined the majority isolated after mutagenesis were
found to belong to the npe A group (Edwards et al
1974 i Holt et al 1976). When naturally occurring
non-producing strains were studied they were found to
belong predominantly to two heterokaryon
incompatibility groups but also to be mostly of the
npe A type (Cole et al 1976). The effects of the
titre increasing pen AI, pen B2 and pen C3 mutations
in various combinations were investigated in
Table 1.1
Complementation
Group
npe A
npe B
npe C
npe D
pen A
pen B
pen C
-20-.
Linkage group location of mutations
affecting penicillin production in
A. nidulans
Linkage
Group
VI
III
IV
II
VIII
III
IV
Reference
Edwards et a1 1974
.1& " ~,
Makins et a1 1983
Ditchburn et a1
.J.976
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ii
i'l:
II
'.'.1
11
"
I
II
:!
heterozygous diploids and in haploid recombinants
from crosses between the mutant strains. Whilst
pen Al was recessive, pen B2 was dominant and pen C3
semi-dominant. Both the pen Al and pen C3 mutations
were epistatic to pen B2 and pen Al was
additionally epistatic to pen C3 (Ditchburn et al
1976).
Crosses between A. nidulans strains with naturally
different titres of penicillin followed by the
quantitative' study of progeny titres have shown
antibiotic production to be poly-genically determined
with many of the genes concerned having additive
effects (Merrick and Caten 1975). Starting with a
sexual cross between two producing strains derived
from different heterokaryon incompatibility groups,
and so with a high input of natural variation,
Merrick has further shown (1976, 1975a) it is
possible to'obtain' a substantial (60-160%) increase
in titre over four or five generations of inbreeding
by continually selecting the highest producing
progeny to be the parents of subsequent crosses.
This would indicate some potential for the use of
breeding ,techniques in titre improvement providing
fresh sources of variation were introduced
periodically, for example by crossing between
separate lines of strain selection (Merrick 1975b).
However, the initial strains fed into the
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hybridization and selection programme by Merrick were
derived from a natural population rather than from
existing strain improvement lines in which recurrent
mutagenesis had previously been used to introduce
titre improving mutations. Simpson and Caten (1980,
1981) attempted to improve titre by crossing strains
derived via two different lines of mutagenesis.
Ethylmethylsulphonate and near ultraviolet light plus
8 -methoxysporalen treatment were used as mutagens.
Strains were crossed and the highest titre progeny
selected as the parents for the next generation.
Although some increase in titre was found, the
presence of non-additive, unfavourable gene
interactions appeared to limit the titre improvements
passible. Whether the presence of genes with non-
additive effects on production is a general
characteristic of strains produced as a result of
programmes of mutagenesis in contrast to the mainly
additive effects of genes found in the strains used
by Merrick is not certain but the poor titre
improvement obtained by Simpson and Caten would
suggest that the use of mutagenesis and hybridisation
together as a means of titre improvement may meet
with a variety of problems as anticipated by Sermonti
(1961).
The .study of penicillin production in P.
chrysogenum has depended upon the use of parasexual
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analysis.
diploids
Early work established that heterozygous
could be formed from strains with
complementary nutritional requirements: following
segregation the diploids gave haploid recombinants
(Pontecorvo and Sermonti 1954: Sermonti 1954). As
in A. nidulans penicillin production was shown to
be largely under nuclear control (MacDonald et al
1963a) and when mutants with reduced capacities to
synthesise penicillin were isolated by Sermonti
(1956) eight out of nine belonged to the same
complementation group. The recessive nature of a
number of non-producing mutants was shown by Caglioti
and Sermonti (1956) and diploids formed from crosses
.between raised titre strains and their progenitors
were generally found to be of low titre suggesting
that the mutations leading to improved titre were
recessive (MacDonald et al 1963b). When strains
with improved penicillin titres were crossed the
diploids formed had varied titres some much reduced
compared to the.parent strains but some comparable to
those of the parents (MacDonald et al 1965: MacDonald
1966). In one cross two thirds of the diploids
examined produced significantly less antibiotic than
the parents and this was proposed to be the result of
a dominant titre reducing mutation arising in one of
the· pa~ental strains and having a selective
advantage e, Calam et al (1976) reported the
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successful production of a diploid of high titre
which had an improved ability to form spores compared
to other high titre strains. This diploid was the
result of both hybridisation and subsequent mutagenic
treatment of the diploids produced. These workers
also tested out various strategies to determine
whether particular types of crosses and the use of
particular mutagenic treatments might be of use in
strain improvement. Their results, however, led to
the conclusion that it would be difficult to predict
which crosses would be most use for improving a
complex system such as antibiotic production.
Analysis of segregants from diploids revealed a
.difficulty in obtaining haploid segregants possessing
alleles from both parental strains. MacDonald
(1968) suggested the occurrence of this parental
genome segregation could be due to the presence of
in one or both of thechromosomal rear~angements
parental strains leading
recombination .or to the
to difficulties in
treatments to enhance the degree
of
of
of
selective advantage
The useparental
chemical
type haploid recombinants.
segregation occurring in these situations was
suggested (Macdonald 1971). This coupled with the
careful choice of the parental strains largely
enabled _> the problem of obtaining a good range of
segregants to be overcome. By crossing closely
related 'sister' strains and using para-
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fluorophenylalanine to induce segregation Ball (1971)
assigned twenty auxotrophic and drug resistance
markers to positions on three linkage groups in a
raised titre strain of ~ chrysogenum so opening the
way for the mapping of induced mutations having titre
increasing effects to linkage groups I and II (Ball
1976).
Normansell et al (1979) have since examined twelve
penicillin non-producing strains der ived from
relatively low-yielding P. chrysogenum lineage and
allocated them to five complementation groups. Of
the twelve mutations, seven belonged to one group (Y)
which is reminiscent of the earlier work by Sermonti
(1956). Three of the five complementation groups
(Y, Wand Z) were located on one linkage group with
the other two being on separate linkage groups.
Biochemical studies have suggested that mutants in
groups X, Y and Z are unable to synthesise the
tripeptide precursor of penicillin with those in
group X additionally lacking the acyl exchange enzyme
required later in the biosynthetic pathway. Mutants
in group V were also deficient in the acyl exchange
step. The npe A mutants of A. nidulans synthesise
penicillin when supplied with ACV tripeptide
su99~stiftg a block at or before tripeptide synthesis
(Makins and Holt 1982) and the functional equivalence
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of npe A and npe Y in P. chrysogenum has been
suggested following the co-fermentation of mycelium
given gentle treatment with a lytic enzyme to weaken
the cell wall (Makins et al 1981). The possible
relationships of the mutations, studied in the two
organisms, to the biosynthetic pathway leading to
penicillin are shown in Fig. 1.3.
1.4 The biosynthesis of CPC.
In contrast to the limited genetic studies of the
CPC production in ~ acremonium, biochemical studies
have produced a relatively detailed picture of the
biosynthetic pathway involved.
The B-lactam compounds present in C. acremonium
fermentation broths are produced by a common
biosynthetic pathway (Fig. 1.4) with Pen N being an
intermediate in the formation of CPC. The pathway
shows many similarities with those for the production
of hydrophobic penicillins by Penicillium species
(for review see Hersbach 1984) and for the synthesis
of the cephalosporin based metabolites of
Steptomyces species (for reviews see Elander 1974;
Kanazaki and. Fujisawa 1975). Variations in the
biosynth~tic pathway (which will be described below)
do OCcur in both mutant strains of C. acremonium and
-27-
Fig. 1.3 Mutations affecting steps in the anti-
biotic biosynthetic pathways in
A. nidu1ans and P. chrysogenum.
L - ~ - aminoadipic acid
t _------L - cysteine
8- (L - ~ - aminoadipic acid) - L - cysteine
A nidulans ~ chrysogenum
mutants mutants
npe A
L - valine
npe Y npe Z
ACV tripeptide
npe C
l
isopenicillin N
l
npe W
npe V
penicillin G
from MacDonald 1983
Fig. 1..4
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The biosynthetic pathway 1.eading to
cepha1.osporin c.
(L) SH
. H2N- CH----C~
C!oH
L - cystine
1:. -fk aminoadipic acid
(L~- aminoadipyl) L - cysteine L - valine
LLD - Tripepbele.
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/CR -(CR2) 3-CO:;='.(=:(
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. ... COOH
i90penicillin N. synthetase
Isopenicillin N
'epimeras~'
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Penicillin N
'expandase'
Deacetoxycephalosporin C
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/g~--(CH2)3-CO~r-T
HOOC J--~,.#
o
'hydroxylase'
Deacetylcephalosporin C COOH
'deacetylcephalosporin C.
acetyltransfr~aser
Cephalosporin C
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in other related species. Many of the compounds
produced as a result have been characterised and
found to be modified versions of intermediates in CPC
bio-synthesis e.g. RIT 2214 a penicillin with a L-S-
carboxymethylcysteine in place of the o<-aminoadipyl
moiety (Troonen et al 1976), or to be the result of
side reactions to the main pathway e.g. C-43-219, the
product of the reaction of D-penicillamine and CPC
(Kanazaki et al 1976). Other examples have been
described by Kanazaki et al 1974, Fujisawa and
Kanazaki 1975a, a Traxler et al 1975, Kitano et al
1976 and Kitano 1977 a and b.
1.4.• 1 The Arnstein tripeptide precursor.
CPC C biosynthesis begins with the formation of the
same ACV tripeptide precursor molecule, the
'Arnstein
I
tripeptide', 8-(L- 0< -aminoadipyl)-L- .
cysteinyl-D-valine as that involved in penicillin
production in P. chrysogenum. (Arnstein and Morris
1960; Loder and Abraham 1971 a and b; Fawcett et al
1976). This is the product of the non-ribosomal
condensation of L-c(-aminoadipic acid and L-cysteine
followed by the addition of L-valine (Trown et al
1962). C. acremonium mycelium or broken cell
preparations do not utilise exogenously supplied 8-(
~-aminoadipyl)-L-cysteine as a precursor for
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tripeptide biosynthesis. The molecule is first
hydrolysed and the subunits are used for tripeptide
synthesis (Loder et al 1969). The L-isomer of
valine is ,preferentially incorporated and the final
LLD configuration of the tripeptide necessary for its
subsequent participation in the formation of
isopenicillin N is produced during condensation with
the O-(L-ct-aminoadipyl)-L-cysteinedipeptide (Demain
1963). Since neither O-d.-aminoadipicacid nor 8-(0-01.
-aminoadipyl)-L-cysteine are readily accepted as
substrates it is apparent that the d-aminoadipic acid
moiety is initially incorporated in the L
configuration with the D configuration of the
penicillin side chain being produced at a subsequent
stage (Warren et al 1967; Loder and Abraham 1971 b,
Fawcett and Abraham 1975). In addition to the ACV
tripeptide two other peptides have been recovered in
low concentrations from C. acremonium mycelium.
Both resemble ACV but have an additional glycine
moiety and in one case a-hydroxyvaline in place
of valine (Loder and Abraham 1971 a and b).
Ring cyclization of the tripeptide.
The ACV tripeptide is converted by a cyclization
reaction. to form a .B-lactam thiazolidinering
structure.. The first experiments in~olving the use
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of radio-labelled tripeptide failed to demonstrate
the incorporation of the molecule into compounds with
antibacterial activity. This was due to the
impermeability of intact· C. acremonium mycelium to
the pre cursor. When protoplast lysates and
other cell free systems were used tripeptide
incorporation was obtained and more detailed studies
have shown that the immediate product of cyclization
is isopenicillin N with the o(-aminoadipic acid side
chain in the L configuration (Fawcett· et al 1976;
O'Sullivan et al 1979; Konomi et al 1979.
-- --
Isopenicillin N synthetase (IPNS), the enzyme
catalysing the cyclization reaction requires ferrous
ions, oxygen and the reduced form of the LLD
tripeptide for activity. It has a pH optimum
between 7.0 and 7.5, and a temperature optimum
between 25 and 30°C (Sawada et al 1980a; Kupka et al
1983a). Purification of IPNS has led to estimates
of its molecular weight ranging from approximately
31,000 (Abraham et al 1980; Kupka et al 1983b) to
41,000 + / - 1,000 (Hollander et al 1984). Pang et
~ (1984a) have noted similarities in the co-factor
requirements of the C. acremonium enzyme and similar
synthetases partially purified from P. chrysogenum
and ~ clavuligerus.
Several groups have examined the utility of
analogues of the ACV tripeptide as substrates for
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IPNS and so function as possible precursors for
penicillin molecules with novel structures.
Analogues showing some activity include the DLD form
of ACV, 8 - (L-carboxymethylcysteinyl) -L-cysteinyl- 0-
valine, phenoxyacety-L-cysteinyl-D-valine and
phenylacetyl-L-cysteinyl-D-valine. However, in all
these cases antibiotic formation is inefficient and
conversion rates are low when compared to those with
the natural substrate (Bahadur et al 1981; Baldwin et
al 1984a and 1985; Wolfe et al 1984). Detailed
investigations of the chemical mechanism and
stereochemistry of the ring cyclization reaction and
the subsequent stages of CPC biosynthesis are in
progress but are beyond the scope of this discussion
(Neuss et al 1973; Kluender et al 1973 and 1974;
Huang et al 1975; Baldwin et al 1981a, 1984b; Pang et
~ 1984b).
1.4.3 The formation of Pen N.
Pen N, with the ct-aminoadipyl side chain in the D
configuration, is the product of an enzyme catalysed
epimerisation. of isopenicillin N. The activity of
the epimerase can be demonstrated in protoplast
lysates in the. presence of FeSO 4' ascorbic acid and
ATP. HOwever, the enzyme is labile and prone to
inactivation if stored in protoplast lysates
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rather than as intact mycelium (Baldwin et al 1981b;
Jayatilake et al 1981). An enzyme responsible for
epimerase activity has been purified from the
cephamycin producing S. clavuligerus and is more
stable and therefore more amenable to study than the
~ acremonium enzyme. It has a molecular weight of
approximately 60,000 and to date no stimulatory
cofactors have been identified (Jensen et al 1983;
Lubbe et al 1986).
The relationship of Pen N to the
cephalosporin compounds produced.
Evidence for the common pathway of Pen Nand CPC
biosynthesis came from two areas of study. Mutant
strains of C. acremonium blocked in the synthesis of
CPC were found to fall into two groups with respect
to B-lactam fo~atio~ (Pen N+ CPC ; Pen N CPC ) with
the production of CPC without Pen N not being
observed. Strains blocked for CPC production
accumulated other types of cephalosporin compounds
identified asdeacetoxycephalosporin C (DAOC) and
deacetylcephalosporin C (DAC). The pattern of
accumulation of these suggested a pathway converting
Pen N first to DAOC then to DAC and finally to CPC
(Fujisawa··et al 1973; 1975a, 1975b; Queener et al
1974: Shirafuji et al 1979). In addition C.
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acremonium cell free systems convert Pen N to a
compound resistant to penicillinase but sensitive to
cephalosporinase activity (Kohsaka and Demain 1976).
The product of such reactions was shown to be DAOC
(Yoshida et al 1978: Baldwin et al 1980, 1981b) thus
strengthening the view that Pen N is an intermediate
in the linear biosynthetic pathway leading to CPC.
1.4.5 Ring expansion to produce
deacetoxycephalosporin c.
The enzyme catalysing the ring expansion of Pen N
into DAOChas pH and temperature optima similar to
those of the ring cyclization enzyme (Kupka et al
1983a) and estimates of
ranged f r orn ·28,000 to
Scheidegger et al 1984).
its molecular weight have
35,000 (Kupka et al 1983b:
For activity in cell free
systems, cl-ketoglutarate as a cofactor, ferrous ions,
molecular oxygen and the presence of ascorbic acid
are required. Low concentrations of ATP are
stimulatory. This would suggest that the enzyme
belongs. to the class of et -ketoglutarate linked
dioxygenases. A membrane bound location for the
ring expans ion enzyme within the cell was sugges ted
but in the· majority of cases the enzyme activity has
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not been found to be associated with the cellular
membranes (Kohsaka and Demain 1976; Hook et al 1979;
Sawada et al 1979, 1980b; Baldwin et al 1980; Kupka
et al 1983b). Investigations into substrate
specificity have shown that penicillin G, ampicillin
and carboxy-n-butyl-penicillin act as non-competitive
inhibitors of the expandase, with no corresponding
cephalosporin compounds being produced (Kohsaka and
Demain 1976; Kupka et al 1983b). Expandase activity
is reversibly lost during the storage of enzyme
preparations
suggesting a
in the absence of dithiothreitol
requirement for the sulphydryl groups
present in the enzyme to be protected from oxidation.
This could be indicative of the function of ascorbic
acid in cell free assays of the expandase (Lubbe et
al 1985a). In comparison to the ring cyclization
reaction the rate of ring expansion is low suggesting
that this step may 'be rate limiting (Kupka et al
1983a).
1.4.6 The formation of deacetylcephalosporin c.
Mutant strains of C. acremonium which fail to convert
DAC into CPC generally produce the accumulated DAC by
~ ~ synthesis from DAOC (Fujisawa and Kanazaki
1975bi' Fujisawa et al 1975b). However, a mutant
with unusual properties has been reported. During
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fermentation this strain begins to accumulate CPC
which is they hydrolysed to give DAC(Fujisawa et al
1973; Fujisawa and Kanazaki 1975c). Accumulation of
DAC by this strain is due to the presence of an
extracellular CPCacetylhydrolase enzyme not observed
in the progenitor strain, which hydrolyses CPC at a
rate greater than that of the non-enzymatic
hydrolysis seen in some fermentations (Huber et al
1968; Fuj isawa et al 1973, 1975c). Other
extracellular acetylhydroxylase enzymes produced by
~ acremonium have been reported (Hinnen and Nuesch
1976). The enzymatic conversion of DAOCto DAC
requires the presence of d-ketoglutarate, ferrous
ions, dithiothreitol, ascorbic acid and oxygen in
cell free systems. The enzyme has a pH optimum of
7.0 and is highly substrate specific. Pre-
incubation of cell extracts with the required
cofactors before addition of DAOCsubstrate has been
reported to cause an increase in the activity of the
hydroxylase of up to ten-fold but these reports are
not consistent (Turner et al 1984; Scheidegger et
~ 1984. The many similarities found between the
hydroxylase and expandase enzymes suggests that DAC
production is also catalysed by an ct -ketoglutarate
linked dioxygenase (Turner et al 1978; Felix et al
1980; Sche.f.degger et al 1984). Scheidegger et al
(1984), dur.ing attempts to purify the two enzymes
-38-
found that both the ring expansion and hydroxylation
activities correlated with a single protein fraction
having a molecular weight of 33,000 +/- 2,000. They
proposed that a single bifunctional enzyme might be
responsible for the conversion of Pen N into DAC.
Support for this view has come from Dotzlaf and Yeh
(1987) and Baldwin et al (1987) who found that the
two enzyme activities remained associated during
purification and appeared to correlate with a single
monomeric protein with a molecular weight of 41,000
+/- 2,000. In contrast the two corresponding
activities present in extracts of S. clavuligerus
have been separated, with the expandase having a
molecular weight of 29,000 and that of the
hydroxylase being 26,200 (Jensen et al 1985).
1.4.7 The formation of cephalosporin C.
The final stage of ,B-lactam biosynthesis in C.
acremonium is the acetylation of DAC to form CPC.
Felix et al (1980) showed the acetyltransferase
enzyme to require acetylcoenzyme A, acetate and ATP
for activity in ether permeabilized cells. Using
cell free extracts Fujisawa and Kanzaki (1975 b) had
previously show~ a requirement for magnesium ions as
a co- .factor. The reaction has a pH optimum of pH
7.0 to 7.4·and acetyltransferase activity has been
-39-
shown to be absent in many mutant strains found
accumulating DAC in preference to CPC.
1.5 The relationship between primary and secondary
metabolism in C. acremonium : fermentation studies.
~-lactam antibiotics are produced as secondary
metabolites by C. acremonium during fermentation.
Production is largely associated with a phase in the
life cycle in which little growth occurs. Pen N may
begin to accumulate whilst cultures are still
actively growing and utilizing rapidly metabolised
carbon sources such as glucose but CPC production is
delayed until a later stage characterised by a
reduction in the rate of increase in cell mass and
the use of other carbon sources. Antibiotic
production continues until a short time after
eXhaustion of the carbon source. Following this
there is a rise in both the pH and ammonium content
of the culture and lytic effects are seen as both CPC
titre and cell mass decrease; Nuesch et al 1973;
Matsumura etal 1978). Although the basic pattern of
antibiotic synthesis remains constant to a degree,
the prec~se timing, rate of production and the
-maximum titres achieved vary between strains and
between· fermentation conditions. A comparison .of
the performance of a number of raised titre strains
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under identical conditions has been made (Perez-
Martinez 1984). Differences in growth pattern in
relation to the carbon source supplied and in the
level of phosphate required for sustained antibiotic
production were seen as well as differing abilities
to convert Pen N into CPC.
1.5.1 Carbon source regulation.
Carbon source regulation of antibiotic production
has been examined using resting cell systems.
Glucose, when present ~ffects mainly the later stages
of biosynthesis, thus lowering CPC but not Pen N
production (Behmer and Demain 1983). Glycerol,
maltose and sorbose have similar effects (Heim 1984).
The ring expansion enzyme responsible for the
conversion of Pen N into DAOC is subject to both
glucose repression and inhibition whilst the
cyclization reaction leading to the formation of Pen
N is only slightly inhibited (Martin et al 1982;
Behmer and Demain 1983; Scheidegger et al 1984). A
decrease in PenN production when glucose is present
in very high concentration has been noted (Heim 1984)
which might be indicative that an enzyme prior to
-IPNS in the pat hway may have some sensitivity to
carbon. source control. Other slowly metabolized
Carbon sources, for example sucrose, galactose,
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fructose and ma~nitol, or a tightly controlled supply
of glucose tend to favour the production of high
levels of CPC (Kennel and Demain 1978; Matsumura et
al 1978). There is no clear evidence as to the
mechanism underlying carbon catabolite repression of
CPC biosynthesis in C. acremonium. Phosphorylated
intermediates of glycolysis, for example glucose-6-
phosphate and fructose-l, 6-bisphosphate, have been
suggested as effectors mediating glucose control of
cephamycin production in StreptomYces lactamdurans
(Cortes et al 1986) and of the production of
hydrophobic penicillins by ~ chrysogenum (Revilla et
al198l). Control of cephamycin production appears
to be via a decrease in ACV tripeptide formation and
repression and inhibition of the ring expansion
enzyme. In P. chrysogenum ACV tripeptide formation
is reduced both by repression and by a lowering in
the intracellular pool concentration of the precursor
oc-aminoadipicacid (Martin et al 1984; Revilla et al
1984; Alvarez et al 1987L
1. 5.2 Regulation by phosphate.
In C. acremonium the effect of phosphate
-concentration on antibiotic production is linked to
that of the'carbon source supply. If the supply of
carbon is tightly controlled to prevent excess carbon
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accumulating then the phosphate level has little
effect, however, in the presence of an excess of a
readily used carbon source metabolism is directed
towards an increase in cell mass rather than
secondary metabolism. Should the supply of either
carbon or phosphate become limiting a switch towards
antibiotic production occurs (Kuenzi 1980). Studies
of cell free systems showed levels of phosphate above
30 mM to repress Pen N formation. The ring
expansion enzyme has also been shown to be sensitive
to phosphate. Below 10 mM phosphate the enzyme is
non-functional but at concentrations greater than 100
mM the enzyme is inhibited. Excess phosphate
therefore tends to reduce the flow through the whole
biosynthetic pathway in contrast to glucose which is
more specific in its repression of the ring expansion
enzyme (Martin et al 1982). Cephamycin production
in S.,_-clavuligerus appears to be regulated by
Phosphate repression and inhibition of ring expansion
and inhibition of ring cyclization with repression
accounting for the major effect (Aharonowitz and
Demain 1977: Lubbe et al 1984, 1985b).
1.5.3 Regulation by nitrogen source.
Until recently information concerning the effect
of different 'nitrogen sources on the CPC biosynthetic
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pathway has been limited. Shen et al (1984)
examined the effects of several inorganic and organic
nitrogen sources and showed that ammonium sulphate,
ammonium chloride, urea and two amino acids, L-
arginine and L-asparagine could be used successfully
to support antibiotic production. High
concentrations of ammonium ions persisting in the
culture to stages at which CPC biosynthesis occurred
tended to decrease the yield of CPC with little
effect on the yield of Pen N. In these conditions
it appears that the ring expansion enzyme is
considerably repressed by the excess ammonium ions
with the ring cyclization enzyme being only slightly
repressed. Addition of an ammonium trapping agent
such as magnesium phosphate can
In Streptomyces species high
reverse the effect.
concentrations of
ammonium ions are thought to cause repression of both
the ring cyclization and expansion enzymes and in
contrast to the situation in C. acremonium, it
appears that the major effect is exerted at the
cyclization step (Brana et al 1985: Castro et al
,1985).
The activity of one particular enzyme involved in
nitrogen 'metabolism has been correlated with CPC
biosynthesis. Glutamate dehydrogenase is
respons1ble for the production of L-glutamate from ~-
ketoglutarate' and ammonium ions. Since both ol-
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ketoglutarate, as a precursor of ~-aminiadipic acid,
and L-glutamate, as a potential amino group donor in
the transamination reactions leading to cysteine and
valine formation, are required for the production of
the precursors of CPC then the activity of glutamate
dehydrogenase might be particularly relevant to
antibiotic biosynthesis (Fig 1.5). A line of mutant
strains of C. acremonium have been produced in which
glutamate dehydrogenase, normally repressed once the
growth phase of a fermentation is completed, is
instead derepressed. Of this group of mutants,
several had increased capacities to produce CPC, and
it was suggested that in these cases that the altered
regulation of the enzyme overcame a previous nitrogen
limitation in antibiotic biosynthesis (Queener et al
1975; Aharonowitz 1980). Experiments with P.
chrysogenum have suggested that a high intracellular
pool of glutamate may cause the induction of enzymes
. .
required for penicillin syn thesi s (Lara et al 1982;
Jaklitsch et al 1985) • Other work though has
suggested that it is the glutamine pool size which is
important (Sanchez et al 1981).
1.5.~ The role of the non-sulphur containing
precursors of CPC
The metabolic pathways leading to valine and ct-
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Fig. 1.5 The role of glutamate dehydrogenase.
glutamate
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ex-ketoadipate
I
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I
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j
ex -aminoadipate
cephalosporin C
From: Queener et al 1975
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aminoadipic acid are shown in Fig. 1.6. Since both
these amino acids function as precursors of CPC
alterations in their metabolism would be expected to
affect the production of antibiotic. Lemke and Nash
(1972) examined a lysine auxotroph of f..=.. acremonium
and found it to be deficient in antibiotic synthesis.
This was thought to be due to feedback inhibition
of one of the early steps of lysine biosynthesis by
exogenously supplied lysine. Such feedback would
result in a decrease in the flow through the
metabolic pathway common to both lysine and 01..-
aminoadipic acid and so would decrease the
availability of the latter for CPC synthesis. This
aminoadipic acid
the observation that supplying C(-
exogenously could restore the
was confirmed by
capacity for antibiotic production. A similar
decrease in the ability to produce penicillin
following lysine supplementation of cultures has been
seen in P. chrysogenum (Demain 1957). Again
addition of (X. -aminoadipic acid could reverse the
effect (Somerson et al 1961). The more detailed
studies on Penicillium have shown that lysine acts by
inhibition and some repression to feedback regulate
the first enzyme of its own biosynthesis, homocitrate
synthase (Goulden· and. Chattaway 1968; Masurekar and
Demain 1~71 and 1974; Friedrich and Demain 1977 a and
b; Luengo et al 1980). Lysine addition may both
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Fig. 1.6 The biosynthetic'pathways 1eading to
a-amino adipic acid and va1ine.
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from Lehninger 1975
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delay the onset of antibiotic synthesis and decrease
its rate and there is some evidence that Penicillium
strains selected as high producers of antibiotic may
have an altered response to lysine so that the onset
of synthesis is not delayed (Luengo et al 1979).
Valine biosynthesis is also subject to feedback
control. In both high and low producing strains of
c. acremonium acetohydroxyacid synthetase is
repressed and inhibited by valine, isoleucine and
leucine with the enzyme being particularly sensitive
to valine (Matsumura and Suzuki 1986).
This is in contrast to the report that valine acts by
inhibition rather than by repression in P.
chrysogenum and that high and
have altered responses to
Chattaway 1969).
low producing stains
valine (Goulden and
1. 5. 5 The role of sulphur metabolism in CPC
production.
Sulphur metabolism,
the production of
particularly with reference to
biosynthesis,
acremonium~
is
precursor cysteine for ,B-lactam
of considerable importance in C.
derived
sulphate
The sulphur atom of cysteine may be
ei ther inorganic sulphur via thefrom
reduction pathway or from methionine via
reverse trans-sulphuration (Fig. 1.7). In C.
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Fig. -1. 7 Sulphur Metabolism.
L-METHIONINE CHOLINESULPHATE
CELL
MEMBRANE
CHOLINE
SUI.JOHATASE
,
CHOLINE
CHOLINE
SULPHATE
II£THYLTlIAHSFERASE
SH~CH2It=H-COOH
L-SERINE . N~~PY~~ATE
CYSTATHIONINE CYSTATHIONINE
~-SYNTHASE ~-LYASE
PAPS
SH-CH3
!S-AlJ(YLCYSTEINELYASE
S-METHYL
L-CYSTEINE
L-CYSTATHIONINE
mmH:~~:I~'<~::<:H'OH'N'
,-LYASE r-s'i'NTHASE 'a-ACETYL
__./' -L-HOMOSERINE
2-oXOBUTYRATE
SUlPHITE RfDUCTAS£
L-CYSTEINE
a-ACETYL
-L-SERINE - L-SERINE
SERINE ACETYL
TRANSFERASE
"o(-AMINOAOIPATy
. //_ O-VAlINE
f3 -LACT AM ANTIBIOTICS
"<, .. S-SULPHOCYSTEINE/"" .
HA"'.,
~es HAOPN ...
esse'
From Perez-Martinez 1984.
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acremonium methionine is generally preferred to
inorganic sulphur for antibiotic production in
contrast to the situation in P. chrysogenum (Tardew
and Johnson 1958; Segal and Johnson 1961 and 1963;
Caltrider and Niss 1966; Nuesch et al 1973). Niss
and Nash (1973) proposed that the inferiority of
sulphate for CPC biosynthesis in C. acremonium is due
to the strict regulation of sulphate assimilation in
this fungus. The preferential usage of methionine
is reflected in the derepression of a sulphatase
enzyme which occurs during antibiotic production.
This enzyme is responsible for the mobilization of
endogenous sulphur stored as choline sulphate and its
conversion into sulphate for use in metabolism.
Normally the sulphatase is repressed to different
degrees by the presence of, for example, methionine,
cysteine or sodium thiosulphate, presumably by the
action of a common intermediate in their metabolism,
possibly sulphate. During antibiotic production the
sulphatase is derepressed in response to the
additional requirement for sulphur generated by the
diversion of methionine and cysteine towards CPC
biosynthesis (Dennen and Carver 1969).
Although methionine is usually preferred by C.
acremonium several mutants have been characterised
which have an increased ability to use inorganic
sulphate and ~o show similarity to P. chrysogenum.
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In one such - mutant the activity of L-serine
sulphydrylase, involved in one of the two pathways for
cysteine production from sulphate, had been doubled.
This strain therefore maintained increased inter-
cellular concentrations of cysteine and was sensitive
to methionine. Addition of methionine above a
certain level would raise the level of cysteine
further so that the enzyme cysteine desulphydrase
would be stimulated leading to the degradation of
cysteine and a lowering of antibiotic production.
(Komatsu et al 1975: Komatsu and Kordaria 1977). A
second type of mutant resistant to DL-selenomethionine
had an increased permeability to sulphate and a
lowered sensitivity to feedback inhibition of sulphate
assimilation by methionine (Matsumura et al 1980).
Methionine is thought to enter C. acremonium
mycelium by two routes. The L-isomer appears to be
t.a ken up
quickly
by a specific amino acid permease, to be
converted into. the D-isomer and then
deaminated producing ammonia as a nitrogen source and
2-keto-D-methiolbutyric acid which is excreted (Benz
et al 1971). D-methionine is believed to enter the
cell at a far slower rate probably via a non-specific
permease and as such is less rapidly utilized and so
may provide a tonger lasting pool for antibiotic
production. There is evidence that the uptake of
methionine is considerably reduced by the presence of
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sulphide in the cell (Benko et al 1967; Nuesch et al
1973, 1976; Demain 1974). Nuesch et al (1973)
proposed that the production of cysteine from
methionine via the action of cystathionine-y-lyase was
essential in order to provide 'active' cysteine
molecules for antibiotic synthesis. This could
explain the relative inefficiency with which
exogenously supplied cysteine functions as a precursor
of CPC.
Although methionine can act as a sulphur donor in
CPC biosynthesis, proposals for an additional role
were made following observations that its action was
not solely consistent with that of a sulphur source in
C. acremonium. Other fungal species which produce
CPC are known to vary in their response to methionine
(Kitano 1977c). From the early stages of
investigation it was noted that the addition of
methionine to fermentations, in constrast to other
sUlphur sources, caused a lowering of the growth rate
as well as an increase in CPC production. The
mycelium present also seemed to become swollen,
irregular arid fragmented, forming arthrospores
(Kavanagh et al 1958; Caltrider et al 1968; Queener
and Ellis' 1975). Later work showed a possible
correlation betw~en the ability of a strain to produce
high titres of antibiotic and the ability to fonn
arthrospores and speculations have been made as to the
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possible causal connections between methionine supply,
differentiation and antibiotic production (Nash and
Huber 1971; Drew et al 1976). In c. acremonium
intermediates of the trans-sulphuration pathway
between methionine and cysteine supplied to a
fermentation in place of methionine do not promote the
same stimulation of biosynthesis as seen with
methionine itself. Some groups have shown that the
non-sulphur containing methionine analogue, DL-
norleucine may mimic the stimulatory effect of
methionine and that S-methyl-cysteine in low
concentrations will improve antibiotic production
(Demain and Newkirk 1962; Demain et al 1963; Caltrider
and Niss 1966; Drew and Demain 1973 and 1975a; Kitano
1977c). The stimulatory effect of methionine has
also been found to be dependent upon its presence
during the growth phase rather than the production
phase of a fermentation (Demain et al 1963; Matsumura
et al 1978) and to still occur even in mutants where
trans-sulphuration .is blocked between methionine and
cysteine (Drew and Demain 1975b). Indeed a strain
carrying a methionine auxotrophy was shown to require
supplementation with methionine to a level above that
required to allow growth if CPC was to be produced
even if an excess of inorganic sulphur known to be
able t6 support some antibiotic synthesis in the
parental straln was provided (Drew and Demain 1975c).
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Several theories have been proposed as to the
precise mechanism of methionine stimulation. Drew
and Demain (1973) suggested methionine might act by
inhibiting cysteine desulphydrase and so having a
sparing effect on the intracellular pool of cysteine
available for antibiotic production. However, they
were unable to demonstrate any effect on this or on
any other enzyme relating to the use of cysteine in
metabolism. Both methionine and norleucine have been
shown to cause, probably by induction, an increase in
the specific activity of the ring cyclization and
expansion enzymes (Sawada et al 1980c). Matsumura et
al (1980) observed that the concentration of
methionine present in the intracellular pool of C.
acremonium rises and peaks approximately ten hours
before CPC production begins. This could indicate
that methionine is in fact acting as a trigger or
indu~er of the enzymes responsible for CPC
biosynthesis.
intracellular
It is interesting to note that for the
methionine concentration to peak in
fermentations with glucose as a carbon source, it is
necessary for exogenous amino acid to remain after the
depletion of glucose. The preferential usage of
methionine' for protein synthesis rather than p-lactam
production whilst glucose remains in the culture
medium has also been examined by Bartoshevich et al
(1985).
. ,
Methionine induction of secondary metabolite
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biosynthesis if present in C. acremonium may operate
in a similar manner to the proposed induction by
tryptophan of ergot alkaloid production in strains of
Claviceps (Bullock and Barr 1968: Robbers et al 1972).
At present the exact mechanism of methionine
stimulation of CPC production is not certain and
awaits further investigation.
CHAPTER 2
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Mutant Isolation and Characterisation
2.1 Introduction
The foundation for the study of the genetics of ~
acremonium was laid by the application of protoplast
fusion techniques to overcome problems associated with
heterokaryon formation in this organism (Hamlyn and
Ball, 1979). This made possible not only the
development of a linkage map but also the examination
of the inheritance of CPC titre.
Ball (1980) for simplicity of discussion,
classified crosses into three main groups depending
upon the degree to which the parental strains are
related. Crosses can be ancestral, involving a
progenitor strain from early in a selective lineage
and a strain produced much later in the same selection
programme; sister, where two closely related strains
\
are crossed; or divergent and involving strains from
different lines of mutagenesis and selection (Fig.
2.1) • This system of classification has been applied
to C. acremonium protoplast fusion crosses.
The first approach used in developing an under-
standing of the genetics of ~ -lactam production in ~
acremonium mainly involved the use of ancestral and
divergent crosses, although some work involved the use
of two sister strains carrying mutations resulting in
an impaired CPC biosynthetic pathway. The polygenic
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Fig. 2.1 Classification of crosses between strains
derived from a common progenitor strain.
'PROGEN ITOR
STRAIN/~ IA1 ,
/ I 81
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2
ancestral
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nature of B-lactam production and the use of quite
distantly related strains have meant that the data
produced from these crosses has been largely
quantitative with
major effects on
the segregation of
titre being quite
genes having
difficult to
observe over the background segregation of many
alleles having pleiotropic effects on titre in the
parental strains. Results have shown though, that it
is possible to detect the association of effective
factors influencing Pen Nand CPC production with
auxotrophic markers when the data are analysed using
biometrical methods (Perez-Martinez 1984). However,
it has not been possible to determine the linkage map
location of any of the major genes coding for the
enzymes directly involved in CPC biosynthesis.
The mapping of genes involved in the biosynthesis
of penicillin in ~ .!!.1dulansand P. chrysogenum has
involved the construction of strains carrying
mutations, which have major effects on antibiotic
production, and the allocation of these mutations to
complementation groups and linkage groups according to
their segregation patterns (Edwards et al 1974:
Ditchburn et al 1976: Normansell et "al1979: Makins et
al 1983). To extend the information available
concerning the genetics
particularly with regard to
major genes involved, it
of CPC production,
the map location of the
was necessary to obtain
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strains blocked .in antibiotic production which were
sufficiently isogenic to allow both recombination
between them without interference due to phenomena
such as parental genome segregation and the detection
of the segregation patterns of the mutations involved
with respect to each other and to other markers. To
this end, the improved titre strain of ~ acremoniurn,
20-2.1 (C0728), was chosen as the progenitor strain
for the construction of a group of mutants blocked in
CPC biosynthesis. Auxotrophic and drug resistance
markers were also introduced where necessary to
facilitate the use of these and other strains in the
Nottingham collection in protoplast fusion crosses.
2.2 Materials and Methods
2.2.1 Strains
The strains used in this work had all been derived
by mutagenesis and selection from M8650 C. acremonium
progenitor strain. Strains 20-2.1 (C0728) and 20-2.9
an ultraviolet induced leucine auxotroph of 20-2.1
were kindly supplied by
Cumbria, U.K. Strain
Glaxochem Ltd.,
20-2.1 (C0728)
Ulverston,
had been
selected through six mutational steps to give an
improved titre of epc. Strain 20-3.1 (N-2) is a
blocked mutant unable to convert the ACV tripeptide
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precursor of CPC- into isopenicillin N and was kindly
supplied by Prof. Y Fuj isawa (Takeda Research
Laboratories, Japan). The arginine auxotroph of
strain 20-2.1 and the leucine auxotroph of strain 20-
3.1 were isolated following ultraviolet mutagenesis by
Perez-Martinez (1984) and have been designated to be
strains 20-2.3 and 20-3.4 respectively.
2.2.2 Culture Conditions
For long term storage cultures were resuspended in
a medium containing three parts horse serum to one
part nutrient broth (2.5% w/v) in 7.5% (w/v) glucose,
lyophilized and kept at 4°C. Once revived cultures
were maintained on slants of Sabouraud medium at 25°C
and when necessary stored at 4°C.
the media routinely ~sed during
The composition of
the isolation and
characterisation of mutant strains of
is given in Table 2.1.
C. acremonium
2.2.3 Ultraviolet (U.V.) Mutagenesis
Mutagenesis was carried out according to a protocol
adapted from that of Hamlyn (1982) for the far ultra-
violet (U.V.) induction of auxotrophy in C.
acremonium. CuI tures were grown on YEA medium to
encourage sporulation. Since the production of
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Table 2.1. Media Composition
Minimal medium (MM)
-1
gl
Glycerol 24 ml
Na N03
KH2 P04
Mg S04.7H20
KCl
2
1
0.5
0.5
Fe S04.7H20
Agar (Difco Bacto)
0.01
20
pH adjusted to 6.8
o
Autoclaved 121 Cr 20 min.
Osmotically stabilised minimal medium (OSMM) was
MM supplemented with 40.9 g NaCl 1-1 to give a
final concentration of 0.7 M NaCl.
Sabouraud Medium Yeast Extract Plus
Cas amino Acids Medium
(YEA/Cas) .
Malt extract Yeast extract
-1gl
12
Bacteriological Peptone 10 Casamino acids 4
Maltose 40 Agar (Sigma) 20
Agar (Sigma) 20
. 0
Autoclaved 121 Cr 20 min.
Autoclaved 1210Cr
20 min.
pH adjusted to 7.5
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CSL medium
Sucrose
-1gl
24 ml
20
4.5
0.5
0.5
Corn steep liquor
Ammonium acetate
Ca S04
Mg S04.7H20
pH adjusted to 7.2
o
Autoclaved 121 er 30 min.
Fermentat'ion medium (fm)
91-1
Soyabean flour 32
Sucrose 30
D-L Methionine 5
Calcium carbonate 1.5
pH adjusted to 6.8
. 0
Autoclaved 121 er 30 min.
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Plug assay fermentation media (pfm)
gl-l
Lab Lemco powder (Oxoid) 8
Soya bean flour 5
Corn steep liquor 5 ml
Ammonium acetate 2
Sucrose 36
Glucose 9
D-L Methionine 3
Agar (Sigma) 30
pH adjusted to 7.0
o
Autoclaved 121 C, 30 min.
Where necessary media supplemented with aminoacids
-1 -1
at 100 ~g. ml and vitamins at 10 pg. ml .
\
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conidia from strains with improved ~-lactam titres was
often poor, mutagenesis was frequently carried out on
suspensions carrying a mixture of small mycelial
fragments and conidia. Suspensions in water were
adjusted to a density of between 106 and 107 colony
forming uni ts per ml.,
-2(2.4 joules m. sec
and exposed to U.V. radiation
-1) for 80 sec with constant
agi tation, to give a theoretical survival level of
between 1 and 10%. Serial dilutions of irradiated
suspensions were then plated onto a recovery medium
(YEA/Casamino acids) and incubated for 7-14 days at
Colonies developing were then transferred onto
master plates of the recovery medium.
2.2.4 Screening and Characterisation of Mutagenised
Populations.
2.2.4.1 Selection of Auxotrophic Mutants.
Colonies were replicated from YEA/Casamino acids
master plates onto minimal medium (MM) using sterile
cocktail sticks. Those which failed to grow were
then tested op a. range of MMplates supplemented with
different combinations of amino acids, vitamins and
nucleic acids after the method of Holliday (1956),in
order to identify their growth requirements. The
antibiotic production characteristics of auxotrophic
-65-
mutants were determined by the methods described in
sections 2.2.4.3 and 2.2.4.4.
2.2.4.2 Selection of Drug Resistance Mutants.
Where the recovery of drug resistance mutants was
required the mutagenised suspensions were normally
plated, at a density of 106 to 107 colony forming
units per plate, onto MM containing a toxic level of
the drug in question and the growth requirements of
the progenitor strain. Colonies which grew under
these conditions were purified and their phenotypes
confirmed.
2.2.4.3 Selection of Mutants Impaired in CPC
Biosynthesis.
Colonies were replicated with sterile cocktail
sticks from master plates.onto 7 mm diameter plugs of
a solidified form of a complex fermentation medium
(PFM). Two plugs were inoculated for each colony to
be tested. Following incubation in a humid
atmosphere, at 25°C for 5 days, the plugs were
assigned positions on assay plates according to a
semi-random arrangement which was designed to minimise
the effects of plug positioning on the results. The
assay plates consisted of two layers of nutrient agar
-66-
in 30.5 cm square glass dishes the top layer of which
was seeded with 0.4-0.7 ml of a fresh nutrient broth
culture of Alcaligenes faecalis ATCC 8750, a bacterium
sensitive to CPC but resistant to Pen N. After over-
night incubation at 28°C the diameters of the zones of
inhibition of bacterial growth around the plugs, due
to the diffusion of CPC present in the plug cultures
into the surrounding agar, were measured with
callipers. Colonies which gave negative results from
both plugs tested and a number of colonies giving only
small zones of inhibition compared to those produced
by control non-mutagenised colonies of strain 20-2.1
(C0728) were selected for further investigation.
2.2.4.4 Fermentation Analysis of Possible Blocked
Mutants.
Fermentation analysis of colonies suspected of
being. impaired in CPC biosynthesis was carried out
according to the protocol outlined in Fig. 2.2.
Sabouraud slant cultures were grown for 7-14 days at
25°C before being used to inoculate the seed stage
culture which was grown in 20 ml of CSL medium in 250
ml Erlenmeyer flasks. After 3 days incubation on a
. -1
rotary shaker (184 rev. mln. at 28°C.) three 4 ml
aliquots of each culture were used to inoculate
triplicate flasks containing 40 ml of a complex
!
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fermentation medium (FM). The flasks were incubated
wi th shaking for a further 5 days before harvesting.
Two 5 ml samples were taken from each flask. One
sample was filtered through a dried and pre-weighed
filter paper (Whatman No. I, 7 cm diameter). The
filter paper plus mycelium was then dried (95°C for 24
h), cooled and reweighed to determine mycelial dry
weight as a measure of culture growth. The second
sample was centrifuged for 15 min at 4,000
in a bench centrifuge to pellet the mycelium and yield
. -1
rev. mln
a clear supernatant which could be used for antibiotic
determination. Bioassay plates were prepared as
described previously except that two sets were made,
one seeded with Alcaligenes faecalis ATCC 8750 the
other with Sarcina lutea ATCC9341 which is sensitive
to Pen N and resistant to CPC. A 6 x 6 or 7 x 7
arrangement of .7 mm dLarneter wells were cut in the
. .
plates and 50 uL samples of the fermentation broth
supernatants were placed· in them. For each shake
flask fermented two 50 ji l, samples were assayed, one
against each of the two bacterial strains. Before
assay for Pen N the supernatants were diluted 1 part
to 3 to prevent excessively large zones of inhibition
being produced. Samples were assigned to well
positions according to a semi-random array designed to
minimize edge effects on the assay plates. Standard
solutions of Pen Nand·. CPC (kindly supplied by Glaxo
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Group Research, Greenford, Middlesex, U.K.) were
freshly prepared at concentrations of 500, 200 and 50
pg.ml-1 and 50 ul aliquots of these were also included
in 9 wells on each of the assay plates. After
overnight incubation at 28°C the diameters of the
zones of inhibition around the sample wells were
measured using callipers. A regression line relating
the zone diameter produced to the logarithm of the
antibiotic concentration was established using the
results from the Pen Nand CPC standard solutions and
used to determine the concentrations of the
antibiotics present in the fermentation broths.
These concentrations were then expressed either as
volumetric potencies, i.e. ).1gof antibiotic ml-1 of
fermentation broth or as absolute potencies, i.e. pg.
antibiotic mg-1 dry cell weight.
2.2.4.5
(HPLC)
High Performance Liquid Chromatography
To obtain more precise information concerning the
operation of the CPC biosynthetic pathway in mutants
showing impaired J3-lactam production samples of the
centrifuged fermentation broths were examined by HPLC.
The HPLC system described by Miller and Neuss (1976),
was used with a Beckman model 114M pump, a model 160
U.v. detector and a mobile phase of 78.4% water, 12%
-70-
acetonitrile, 8~ methanol and 1.6% glacial acetic
acid. Absorbance at 254 nm was monitored and
standard solutions of Pen N, deacetoxycephalosporin C
(DAOC), deacetylycephalosporin C (DAC) and CPC were
used to facilitate the calibration of the
chromatograms with a Shimadzu model CR3A Chromatopac
integrator.
HPLC separations were typically performed at a flow
-1
rate of 2 ml min at a sensitivity of 0.05 Auf and
. -1
chart speed of 1 mm mln
2.2.4.6 Biochemical Assays of Enzymes Involved in
CPC Biosynthesis.
The activities of two enzymes involved in the CPC bio-
synthetic pathway were examined in cell free extracts
prepared from C. acremonium cultures grown under
fermentation conditions.
2.2.4.6.1 Preparation of Cell Free Extracts.
Mycelium samples were recovered over a period of
several hours from shake flask fermentations in FM
medium, -1by centrifugation at 3,000 rev. min. for 10
min. The mycelium was washed in 50 mN Tris.HCL, 5 mM
EDTA pH· 8.0 buffer and again centrifuged to pellet.
The mycelial samples were frozen in a dry ice/ethanol
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bath and stored at -15°C. until use. Crude cell
extracts were prepared by grinding the frozen material
with sand, resuspending in 100 mM Tris.HCl pH 8.0 and
centrifuging (15,000 rev.min.-1, 5 min.) to pellet the
cell debris. Supernatants were taken as cell
extracts and stored on ice.
2.2.4.6.2 Assay of Isopenicillin N Synthetase
Activity.
Isopenicillin N synthetase (IPNS) catalyses the
conversion of the ACV tripeptide precursor molecule of
CPC to isopenicillin N. Its activity may be
monitored by virtue of the fact that the end product
of the reaction, isopenicillin N, will react with a
mixture of imidazole and mercuric chloride to give a
chromophore the presence of which may be detected as
an increase in optical,density at 320 nm of a reaction
mixture when compared to a blank sample. The
protocol used to assay IPNS activity was kindly
supplied by Glaxo Group Research Ltd., Greenford,
Middlexex, U.K.. Assays were carried out in a total
volume of 1 ml of reaction mixture as described in
Table 2.2'. Blanks were included for each assay with
500 uL of 0.5 M Tris.HCL pH 8.0 replacing the ACV
tripeptlde substrate. Reaction mixture were
incubated at 30°C for 10 min. and were stopped by the
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Table 2.2
Isopenicillin N synthetase assay reaction mixture
Stock Volume Final
Component Solution Added Cone.
mM J.lI
ACV monomer 2mM 500 pI ImM
(in 0.5M Tris HCl)
pH8.0
Ascorbic acid 20 mM 10 pI O.2mM
FeS04 .7 H2O 5mM 10 ).11 50 )-1M
B-mecaptoethanol 100 mM 10 )Jl 1 mM
Cell extract in 100mM Tris. HCl 25-400 pI
pH 8.0
Tris HCl pH 8.0 lOO mM to 1 ml
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addition of 5- ml of imidazole/mercuric chloride
reagent.
solutions
The reagent was prepared by combining
A (8.55g imidazole dissolved in
approximately 70 ml of water and adjusted with
concentrated HCl to give a pH of 65.8) and B (0.027g
of mercuric chloride dissolved in approximately 20 ml
of water) and adjusting the volume to 100 ml with
water. After standing at room temperature for
between 30 and 50 min. the A320 of the reaction
mixtures were then read against the respective blanks.
A standard curve relating the A320 to penicillin
concentration was prepared using reaction mixtures
containing a range of concentrations of penicillin G
in place of the ACT tripeptide substrate and enzyme
extract. Penicillin G was used to construct the
standard curve due to difficulties in obtaining pure
preparations of Pen N.
2.2.4.6.3 Assay of AcetylCoA:deacetylcephalosporin C
O-acetyltransferase Activity.
The final step of CPC biosynthesis involves the
acetylation of DAC. A method for the assay of the
enzyme res'pon,si.bLe for this reaction was adapted from
that described by sch eidegger et al (1985). Cell
extracts were added to the reaction mix described in
Table 2.3 and incubated at 30°C. for 30 min. Rather
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Table 2.3
Acetyl CoA: deacetylcephalosporin
acetyltransferase
assay reaction mixture
Component
Stock
Solution
mM
Volume
Added
pl
DAC 100 mM 20 pI
AcetylCo~nzyme A 10 mM 20 j..ll
Cell Extract in 100 mM TRis. HCl 20-500 j..ll
pH 8.0
Tris. HCl
MgC12 6HZO
100 mM
5 mM pH 8.0 to lml
C 0-
Final
Conc
2mM
200 pM
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than monitor the formation of CPC by HPLC as in the
published method, the possibility of using a spectro-
photometric assay was investigated. When DAC is
acetylated to yield CPC the acetylCoA used as the
acetyl group donor yields free CoA-SH. This will
react with 5,5'-dithiobis (2-nitrobenzoic acid) (DTNB)
to give CoAS-TNB plus thionitrobenzoic acid (TNB+)
(Fig. 2.3). The liberated TNB+ gives a yellow
colouration to the reaction mixture of pH 8.0 which
may be quantified in terms of abs'o.rbe nce at 412nm.
Since the yield should be in proportion to the amount
of CPC produced addition of DTNB to the reaction
mixture at the end of the assay and monitoring the
A412 of the mixtures should give a measure of the
acetyl CoA:deacetylcephalosporin C O-acetyltransferase
activity in cell free extracts. Therefore after the
30 min incubation DTNB was added to the reaction
mixtures to a final concentration of 200uM and the
A412 monitored. Three control reactions were carried
out for each assay in which either the DAC, cell
extract of DAC plus cell extract portions of the
reaction mixture were replaced by buffer. These
allowed the monitoring of background non-DAC specific
acetyltransferase activities.
The activity of citrate synthase which catalyses
the condensation of acetylCoA with oxaloacetate to
give citrate and free CoA-SH in the cell extracts was
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.Fig. 2.3 Scheme for tlie reaction of 5 I, 5 I -
dithiobis(2-nitrobenzoic acid) (DTNB)
with CoA-SH
eaaH eaOH
S
I
S
+COA-SH ...~ ,___._
S
I
+
SH
eOOH eaOH
DTNB Thionitrobenzoic acid(TNB +)
From: Lehninger 1975
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also monitored. Oxaloacetate was added to a final
concentration of 20pM in the reaction mixture in place
of the DAC substrate. This reaction served as an
internal standard ensuring that cell breakage and
enzyme release had occurred during the preparation of
the cell extracts tested.
2.2.4.6.4 Preparation of Acetyl Coenzyme A.
Acetyl CoA was prepared from CoASH by the method
described by Ochoa (1955). CoASH (Sigma) 50 mg was
dissolved in 4 ml water and a 10ul sample removed for
the control test. NaHC03 (0.4 ml of a 1M solution)
plus 7pl of acetic anhydride were added with vigorous
mixing and the mixture incubated on ice for 20 min
before a further 10pl sample was removed. To test
for the removal of the sulphydryl groups from CoASH
20pl of a stock solution of DTNB plus 900pl of 500mM
Tris. HCl pH 8.0 were edded to the two 10pl samples
saved during the preparation. The first sample
would produce a yellow colouration due to the presence
of CoASH and the second sample would only produce a
yellow colouration if some CoASH remained after
reaction with acetic anhydride. As some CoASH
remained the pH of. the solution was adjusted to
approximately pH 7.5 and further acetic anhydride was
added until no reaction with DTNB was seen. The pH
-78-
of the acetyl CoA solution was then adjusted to pH 6.5
with O. 1 N HCl and the solution stored at -20°C until
use.
2.2.4.6.5 Protein Determinations
The protein content of cell free preparations was
routinely determined using the Bio Rad Protein Assay
reagent (BioRad Laboratories) according to the
manufacturer's instructions, with bovine serum albumin
as a standard.
2.3· Results
2.3.1 Induction and Characterisation of Auxotrophic
Mutations.
u.v. mutagenesis of strains 20-2.1 (C0782) and two
other strains derived f·rom it, 20-2.9 and 20-2.3
carrying requirements for leucine and arginine
respectively, resulted in the isolation of a number of
strains carrying new auxotrophic requirements. Table
2.4 shows the identification of these and their anti~
biotic titres, where available. Auxotrophic
requirements were also introduced into several of the
blocked mutants derived· from 20-2.1 and the resulting
strains are listed in Table 2.5. Mutagenesis of the
-79-
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blocked mu tants- was carr ied out using cu l,ture s grown
from single colony isolates, the antibiotic production
characteristics of which had been verified, for
strains 20-2.27, 20-2.35 and 20-2.26 by bioassay of FM
plug cultures and for strain 20-2.32 by the
biochemical assay of IPNS activity. However, despite
this the auxotrophic strains derived from 20-2.32 when
assayed produced a small amount of activity against
Sarcina lutea ATCC 9341 revealing the production of
low amounts of Pen N.
2.3.2 Induction and Characterisation of Drug
Resistance Markers.
Resistances to 6-azauracil and 2-(4" -thiazoly)
benzimidazole (thiabendazole TBZ) were introduced into
a number of strains for possible future use as either
I
selectable or secondary markers in protoplast fusion
crosses. Table 2.6 details the strains obtained.
Where these were to be used in crosses their anti-
biotic titres were confirmed by plug assay. Strains
selected for thiabendazole resistance showed varying
levels of resistance to this compound and Table 2.7
compares the resistance of a number of isolates of 20-
2.11 after u.v. mutagenesis and selection on 25J.lMTBZ.
----------------
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2.3.3 Isolation of Mutants Impaired in CPC
Biosynthesis.
u.v. irradiation of spores and small hypha I
fragments from the raised titre strain 20-2.1 led to
the isolation of a number of strains with reduced
capacities to produce CPC. The surviving populations
from two mutagenesis experiments were screened by plug
assay. Of 491 isolates screened following the first
mutagenesis 17 were chosen as potential mutants and
further examined in shake flask cul,tures. From the
second mutagenesis 18 out of 550 isolates were
selected. All of these were prototrophic. Since
the aim was to produce blocked mutants, the phenotypes
of which could be readily observed segregating amongst
the progeny from crosses, the first group of mutants
examined closely were those showing a complete absence
, \
of CPC production when shake .f Lask fermentation tests
were carried out. Of the four strains falling into
this class, isolate 19/5, which at first appeared to
be a non-producer of Pen N, when subsequently
fermented did produce substantial titres of Pen N.
Over two fermentations this isolate gave an average of
65.4% of the Pen N titre and 20.6%. of the CPC titre
of the control 20-2.1·producing strain. As a result
of this observation isolate 19/5 was not considered
desirable for use as a blocked mutant in future
-85-
crosses although its reduced titre phenotype might
warrant further investigation. Isolate 129/13 on
fermentation appeared blocked before Pen N in the
biosynthetic pathway and isolates 10/2 and 18/16
produced some Pen N but no CPC. Examination of a
fresh culture of isolate 18/11 showed that this too
had similar characteristics to isolates 10/2 and 18/16
and it was added to the group of mutants for further
study. In addition, two isolates, 136/9 and 142/9
were selected as examples of strains which though
still competent for the whole of the CPC biosynthetic
pathway, produced lowered B-lactam titres.
2.3.4 HPLC Characterisation of Mutants Impaired in
CPC Production.
Fermentation broths of the six mutants selected
were examined by HPLC. The system used, allowed the
detection of the intermediates involved in CPC
biosynthesis subsequent to the formation of the ACV
tripeptide, with the exception that it was not
possible to distinguish between isopenicillin Nand
Pen N. The separation of standard samples of
isopenicillin N, Pen N, DAOC, DAC and CPC which could
be obtained is shown in Fig.2.4. The performance of
four of the mutants in one five day fermentation
experiment compared to that of a control 20.2.1
-86-
Fig. 2.4 H.P.L.C. separation of Pen NI
Isopenicillin N, DAOC, DAC and CPC
standards.
Pen N
--========================-- 15 • ':; : DAOC
-===============-22. 4"?2 DAC
~============::::======~. ~:O~~_ .. "_, _"", CPC
Footnote Sample volume was 20 ~l containing 5 Pg
of each standard compound.
Retention times are shown in minutes.
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fermentation is detailed in Table 2.8. The presence
of ACV tripeptide could be observed but the low
absorbance at 254 nm of this compound coupled with its
occurrence as a dimer in the broths complicates its
detection so that the values given are only
approximate. Pen N titre values calculated from
bioassay data are also included in Table 2.8 and show
a discrepancy with the values obtained by HPLC.
Constituents of the fermentation broths, not related
to the CPC pathway resulted in peaks of absorbance at
254 nm early in the chromptographic separation. The
most likely explanation for the abnormally high
isopenicillin N/Pen N HPLC results would appear to be
the co-elution of one of these with the antibiotic
peak. Chromatograms of fermentation broths from 20-
2.1 (C0728) and mutants 18/11 (20-2.35) cnp-6 and
18/16 (20-2.26) cnp-l are shown in Fig. 2.5. Strain
20-2.35 produced a 614.9 pg.ml-1 Pen N and strain 20-
2.26 173.7
. -1
llg.ml . Neither of these strains
produced any intermediate on bioassay subsequent to
Pen N in the pathway.
2.3.5 Isopenicillin N Synthetase (IPNS) Assay
The level of IPNS activity present in cell extracts
of three· strains was examined. Strain 20-2.1 was
compared to both 20-3.1 cnp-7 known to be deficient in
-88-
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Fig. 2.5 H'.P.L.C. separation of fermentation broths
from strains 20-2.1 (C0728). 20-2.35
(cnp-6) and 20-2.26 (cnp-1)*
20-2.1
.;:;Pen,.tJ
DAOC
18.277
DAC
~':'."': ... , I
CPC
L__ ':,,_.
20-2.26 CI).p-l
--Pen N
*,results are from separate fermentation
experiments.
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the production of isopenicillin N and to 20-2.32 (cnp-
~ the U.V. induced blocked mutant suspected of
resembling 20-3.1 in lacking IPNS activity. As Pen N
formation commences q~ite early in C. acremonium
fermentations cell extracts were prepared from 72h.
shake flask fermentation cultures in the first
instance. Assays of extracts made at later stages of
the fermentation showed that IPNS activity in 20-2.1
declines after 72 h. (Table 2.9). Extracts from a
72h. culture of strain 20-3.1 as expected showed
negligable IPNS activity. the level being below the
limits of detection (Table 2.10). On comparison of
the IPNS activity present in 20-2.32 with that in 20-
2.1 it was found that whilst the mutant had a much
reduced capacity to synthesise isopenicillin N,
showing only 24.3% of the IPNS activity present in the
control, some synthesis was occurring (Table 2.11).
This prompted a closer examination of strain 20-2.32.
Bioassay of single colony. isolates grown on plugs of
FM revealed that several of the colonies tested
produced a small zone of inhibition on plates seeded
with Alcaligenes faecalis ATCC 8750. Therefore, the
original culture was suspected to have been mixed and
a non-producing isolate of strain 20-2.32 was selected
and the IPNS assay repeated this time showing the
absence of IPNS activity (Table 2.12).
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2.3.6 AcetylCoA:deacetylcephalosporin C 0-
acetyltransferase Assay.
Attempts to adapt the assay method of Scheidegger et
al 1985 for use with crude cell preparations were
unsuccessful. The use of DTNB and a
spectrophotometric assay of activity, rather than HPLC
analysis, to detect the amount of CPC product formed
appeared to be feasible. Assays of citrate synthase
activity using this system were successful in
demonstrating that cell breakage had occurred with the
DTNB reaction allowing the monitoring of the activity.
However, no release of TNB+ above that occurring in
the blank controls was seen when DAC acted as
substrate. HPLC analysis of reaction mixtures
revealed that there was no CPC formation occurring and
a variety of changes were made to the assay protocol
to attempt to remedy the situation. For example,
cell extracts from 96 h. cultures were tested to check
for the presence of enzyme activity later in the
fermentation than expected, but no activity was seen.
Addition of phenylmethylsulfonyl fluoride (PMSF) as a
protease inhibitor to the cell extracts and the
purification of extracts by either dialysis or
ammonium sulphate precipitation also failed to improve
the assay. A similar result was obtained when a
variety of concentrations of freshly prepared
-94-
acetyl CoA were used. It is possible that the
failure of the enzyme assay was due to insufficient
purification of the crude cell extracts as the
protocol from which the assay was adapted did involve
more sophisticated protein purification techniques but
no further attempts to purify the enzyme were made.
2.3.7 Strain Stability
During examination of the phenotypes of the blocked
mutants derived from strain 20-2.1, it was noticeable
that after sub-culturing there was a tendency for
cultures previously showing a complete lack of ability
to produce one or more of the ~-lactams of interest on
fermentation, to produce a low titre of the
compound(s). When single colony isolates of these
cuLtures were examined by plug assay, it was usually
found that a small number produced the B-lactam
concerned whilst most remained negative. The use of
single colony isolates with confirmed titre
characteristics allowed work to progress. However,
the problem was more acute with strain 20-2.32.
Biochemical assay of IPNS activity allowed the
selection of an isolate showing no detectable activity
for this enzyme. Auxotrophic markers were then
introduced; however, when the marked strains were
assayed for·~-lactam production a small amount of Pen
-95-
N was detected.
2.4 Discussion
To facilitate future investigations into the
genetic basis of CPC biosynthesis, a programme of
mutagenesis was initiated.
areas.
A group of strains carrying mutations affecting the
CPC biosynthetic pathway were derived by U.V.
mutagenesis from the improved titre strain 20-2.1.
This covered two main
The mutations induced were characterised with regard
to the effect they exerted on the production of
intermediate compounds in the CPC biosynthetic
pathway. The apparent blocks in biosynthesis found
may be an indication that the mutations affected
either structural or regulatory genes concerned with
CPC biosynthesis and further biochemical and genetical
studies would be required to clarify this. HPLC
analysis coupled with Pen N determinations by bioassay
showed strains 20-2.27, 20-2.35 and 20-2.26 to be
deficient in the conversion of Pen N into DAOC, i.e.
in the ring expansion step of CPC biosynthesis.
However,·whilst 20-2.35 produced high levels of Pen N
the other two strains produced lower levels of Pen N
than the pro-genitor strain 20-2.1. This could
indicate a reduction in the flow of intermediates
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before Pen N in the pathway , although it might be
expected that some conversion of Pen N into DAOC would
be seen if the ring expansion enzyme was functional.
Strains 20-2.28 and 20-2.29 both appear to be examples
of mutants with a reduction in the flow of inter-
mediates through the whole pathway. The remaining
strain 20-2.32 appeared unable to synthesise
isopenicillin N and as such resembled the Takeda IPNS
mutant 20-3.1. It is not known whether the low level
of Pen N/isopenicillin N detected in fermentation
broths of 20- 2.32 represented a true production of
these compounds at a level below that detectable by
the other assay methods employed or was purely the
result of the co-elution of medium constituents. The
use of other HPLC systems designed to separate Pen N
and isopenicillin N from other substances present in
fermentation broths would clarify this. It is
notable that strains blocked between DAOC and DAC or
between DAC and CPC were not obtained. Scheidegger
et al (1984) and Dotzlaf and Yeh 1987 have proposed
that one protein is responsible for both the ring
expansion of Pen N to form DAOC and the hydroxylation
of DAOC to give DAC in C. acremoni urn and this could
have implications with respect to the types of mutants
isolated.
The lack of detection of mutants deficient in the
conversion of DAC into CPC could be the consequence of
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the selection. procedure adopted. If such mutants
were leaky, allowing some CPC production as in the
case of the Takeda mutant M40 (20-3.2) then a more
detailed examination of strains with reduced CPC
titres needs to be carried out in order to detect
those accumulating DAC. Further mutagenesis to
introduce auxo-trophic and drug resistance markers was
carried out on the strains blocked in CPC production
to enable their use in protoplast fusion crosses. As
noted in section 2.3.7 the auxotrophically marked
strains derived from 20-2.32 were found to produce a
small but detectable amount of Pen N on bioassay.
Problems
production
previously
associated with variable
during the isolation
been
of
antibiotic
encountered
the blocked
characteristics had
strains. The use of mixtures of uninucleate spores
and small hyphal fragments which could have contained
more than one nucleus per colony forming unit in the'
mutagenesis procedure may have led to the original
isolation of mixed cultures following mutagenesis.
Heterogeneous cultures may also have been isolated if
D.V. mutagenesis in ~ acremonium gave rise to mosaics
as in yeast (Nasim and Auerbach 1966). These
problems, appeared to be overcome by the purification
of single colony isolates although it was possible
that some heterogeneity may have remained.
In the case of strain 20-2.32, however, the IPNS
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deficient nature of a single colony isolate had been
biochemically verified before the introduction of
auxotrophic markers, and the reason for the
restoration of a low level of Pen N production appears
unclear. It is possible that the variation in
antibiotic production by these mutants was not due to
the isolation of mixed cultures but to the occurrence
of a second mutation which modified or suppressed the
effects of the first.
A detailed genetic analysis of
question would be required to
possibility.
The second main area covered by the programme of
the strain(s) in
investigate this
mutagenesis was the construction of marked strains
suitable for use in studies aimed at mapping mutations
affecting the CPC biosynthetic pathway.
Auxotrophically marked strains were already available
for mapping studies following the work of Hamlyn
(1982) and Perez-Martinez (1984) and included one
strain 20-1.4 (azu-l arg-l mor-l leu-l red-l pyt-l
ben-l) which covered markers on 7 of the 8
established C. acremonium linkage groups. However,
the use of such strains in crosses designed to map
mutations reducing CPC titre presents two problems.
Firstly, theauxotrophically marked strains were
derived from the low CPC titre M8560 progenitor strain
and consequently the segregation of genes affecting
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titre might be anticipated to be difficult in crosses
involving such strains. Secondly, the divergent nature
of the M8650 strains and the 20-2.1 derived blocked
mutants could suggest that barriers to recombination
would be encountered in crosses between the two
lineages. Therefore, it was considered desirable to
develop the marked derivatives of strain 20-2.1 shown
in Fig. 2.6for use in future mapping work. A number
of markers were also introduced into the Takeda IPNS
deficient strain (20-3.4) to facilitate its use in
crosses.
The introduction of auxotrophic markers into
antibiotic producing P. chrysogenum strains is
reported
reduction
to occasionally result
in titre (MacDonald
in a loss of or
continued subculturing of strains
1963) as has the
(MacDonald 1968).
Following the introduction of markers into strain 20-
2.1 and the subcult4ring necessarily.involved in this
procedure, many of the marked strains produced have
greatly reduced titres. Strain 20-2.33, however,
showed little reduction in titre making this a
promising strain for future mapping work, although the
inclusion of further markers, e.g spontaneous
resistance markers, would enhance its value even more.
Fig. 2.6 shows· the 20-2.1 derived strains available,
at the conclusion of this programme of mutagenesis,
for use in the genetic studies described here.
CHAPTER 3
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Genetic Analysis in C. acremonium Strain 20-2.1
3.1 Introduction
Previous work with the protoplast fusion system
developed for use in C. acremonium resulted in the
establishment of a linkage map (Hamlyn, 1982 ~ Perez-
Martinez, 1984). The markers positioned on this map
were all induced in isogenic strains derived from the
M8650 low CPC titre progenitor strain. Crosses
between M 8650 marked strains and strains derived from
improved titre lines illustrated the complex nature of
the genetic basis of B-lactam production in this
organism, with many alleles affecting titre
segregating in each cross. Two effective factors,
one for Pen N and one for CPC production were located
on linkage groups VIII and VI respectively (Perez-
Martinez, 1984).
To extend the understanding of the genetic basis of
CPC biosynthesis further crosses aimed at relating
mutations affecting titre to linkage groups, def ined
by auxotrophic and drug resistance markers, are
necessary. As the segregation of alleles influencing
titre may be more easily observed when strains from
lineages of hi~hertitre than the M8650 line are used
the work described here has made use of the strains
derived from 20-2.1 discussed in the previous Chapter.
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Two groups of protoplast fusion crosses were
performed. The first were between auxotrophically
marked strains and designed to give information
c9ncerning the linkage group relationships between
several of the markers available in the 20-2.1 series.
The second group involved were crosses between a
marked 20-2.1 strain which had retained a raised titre
of CPC and blocked mutants produced from 20-2.1.
3.2 Materials and Methods
3.2.1 Strains and Culture Conditions
The strains used were as described in Chapter 2.
Cultures were maintained on slants of Sabouraud's
medium. Following fusion protoplasts were cultured
on selective media based on a minimal medium (MM)
osmo ti.ceLl.y stabilised by the addition of O.7M NaCl
-1(40.9 g.l ). The other media used are described in
Table 2.1.
3.2.2 Protoplast Isolation and Fusion
The methods for protoplast isolation and fusion
were based on those used by Hamlyn (1982) and Perez-
Martinez (19B4). Shake flask cultures (20ml CSL
medium supplemented with the appropriate growth
-104-
requirements) were inoculated with mycelium scraped
from Sabouraud slant cultures and incubated on a
t h k (184 . -1 at 28°C) for 48 h toro ary s a er rev. mln.
provide a seed culture. Four ml of this was used as
inoculum to shake flasks containing 40 ml CSL medium
(after the removal of the sediment present in the
medium) plus growth requirements, and the incubation
continued for a further 24 h. Mycelium was harvested
through sintered glass filters (porosity 1), washed
with water followed by buffer solution A (McIlvaine's
phosphate-citrate buffer, 0.2M NaHP04, O.lM citric
acid, pH 7.3) and transf erred to 100 ml conical
flasks. Buffer A (20 ml) supplemented with 0.02M ~-
mercaptoethanol was added and the mycelium incubated
with gentle shaking for 10 min at 28°C. Following
fil tration and washing with water, the mycelium was
recovered on discs of filter paper, transferred to the
\
lytic digestion mixture in a ratio of 1 to 10 (weight
to volume) and incubated with gentle shaking at 28 °C
for 3 h. The digestion mixture was prepared by
dissolving 10 -1mg.ml Cellulase CP (John E Sturge
Ltd. , Selby, N. Yorks. U.K.) plus 5 mg. -1ml
Novozym 234 (Novo Enzymes, Farnham U.K.) in buffer B
(0.2M Na2HP04, O.lM citric acid, 0.7M NaCl pH 4.0).
The enzyme solution was centrifuged, 18,000 rev.min-1
for 30 min at 4°C to pellet any contaminating debris.
Where necessary the enzyme mixture was stored frozen
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at -20°C or for periods of up to 24 h at 4°C.
After incubation mycelial debris was removed from
the lytic mixture by slow centrifugation (1,000
. -1
rev..ma,n for 3-5 mins). Protoplasts were then
pelleted from the supernatant (2,000-3,000 . -1rev. rru,n
for 5 min), re-suspended and washed twice with osmotic
stabilizer (0.7M NaCl). An equal number of
protoplasts from the strains to be fused were mixed
together and control platings were made on plates of
the selective media used in the recovery of fusion
products. The protoplasts were then pelleted and re-
suspended in 1.5- 2.Oml polyethylene glycol solution
(30% PEG molecular weight, 8,000 in 0.05M glycine,
O.OlM CaC12 pH 7.5). After incubation at room
temperature for 10 min approximately 8 ml osmotic
stabilizer were added and the protoplasts pelleted
(2,000-3,000 rev.min -1 for 5 min). The pellet was
then washed twice with osmotic stabilizer by
resuspension and centrifugation to remove any
remaining PEG. The protoplasts were resuspended in a
suitable volume of osmotic stabilizer before plating
and incubation at 25°C.
3.2.3 Control Platings and the Selection of Fusion
Products.
Two types of selectant were recovered following
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protoplast fusion in C. acremonium: quickly growing
haploid recombinants arising from the rapid
degeneration of a transient diploid stage and slower
growing heterozygous colonies, assumed to be aneuploid
for one or more linkage groups and which on subculture
yield sectors of haploid recombinant growth. Two
selection strategies were employed to allow the
separation of the products of protoplast fusion from
trie parental strains used. One was dependent upon
the presence of non-allelic auxotrophic markers in
each parental strain and the other allowed fusions in
which one of the parental strains was prototrophic to
be carried out. After PEG treatment protoplasts were
initially plated on cellophane discs overlaid on
appropriately supplemented OSMM. After incubation
for a period of time to allow for the regeneration of
cell walls the cellophane discs were transferred onto
I
appropriately supplemented MM. The technique of
cellophane transfer was.developed by Hamlyn (1982) to
lessen problems encountered due to the syntrophic
growth of parental strains on selective media.
Plating a mixture of the two parental protoplast
suspensions before treatment with PEG on the selective
media to be used in a given fusion gave a measure of
the background syntrophic growth which would still
occur and also acted as a control for marker
reversion. Protoplasts of the parental strains were
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also plated separately on the selective media or on a
series of media each lacking one of the strain growth
requirements to detect any reversion of mutations or
leaky growth which might occur. Control platings on
media supplemented with the parental growth
requirements were made to check the viability of the
parental strains both before and after treat-ment with
PEG. Protoplast suspensions appropriately diluted in
water were plated out to determine the degree of
contamination of the suspensions with osmotically
stable hyphal fragmentsA
3.2.3.1 Selection Based on Auxotrophy
Where the parental strains to be used in an
experiment each had one or more auxotrophic markers,
products of the cross were selected by plating the
\
fused suspensions on cellophane discs on a range of
media supplemented in such a way that each lacked one
of the growth requirements of each parental strain
(Fig.3.1a). After 4 days the cellophane discs were
transferred as described and incubated for a further
14 to 21 days. Putative haploid recombinants were
purified by plating mycelial fragments, resuspended in
water, on a second plate of the selective medium from
which they had been isolated. Colonies developing on
these plates were transferred to master plates and
-108-
Fig. 3.1. Methods for the se1.ection of fusion products.
a) Se1.ection based on auxotrophy
Parent A Parent B
Auxotrophic
Markers W~/Z
Fusion
Selection of t
fusion
products on
media: -----,l ..~ OSMM +W +y
OSMM +W +z
OSMM +x +y
OSMM +x -z.
Transfer of
'fusion products
on cellophane
discs to MM
supplemented in
the same combin-
ations.
b) Selection based on auxotrophy and drug resistance.
Auxotrophic/
Drug resistance
PC!r~ t A Paren t B S
"<;/totroPh x
Fusion
1st selection against
parent A
I
OSMM
,
---~ ..-- Transfer of
fusion products
on cellophane discs
time for expression
of drug resistance
marker
2nd selection against
both parents
MM +X
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replicated onto a range of diagnostic media to
determine their phenotypes with respect to any non-
selective markers present. Presumptive heterozygous
colonies were streaked out on plates of YEA/Casamino
acids medium to observe the development of recombinant
sectors which could then be purified by plating
resuspended mycelial frag-ments on the same medium to
give single colony isolates for genetic analysis .
3.2.3.2 Selection Based on Auxotrophy and Drug
Resistance.
A selection system similar to that used by Bradshaw
and Peberdy (1984) and Perez-Martinez (1984) was
adapted to allow the selection of recombinant progeny
following the fusion of two strains, one prototrophic
and the other hav Lnq auxotrophic markers and a drug
resistance marker. Selection against the auxotrophic
parent was achieved by plating on media lacking one of
the growth requirements of the strain and selection
against the prototrophic parent was by transferring
the fusion mixture, plated on cellophane discs to MM
supplemented with a toxic level of the drug to which
the auxotrophic parent was res istant Fig. 3.lb. A
period of time prior to exposure to the toxicant was
necessary to allow expression of the resistance gene
before selection couLd be effected. Trial transfers
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of protoplasts inoculated on cellophane discs to media
supplemented with a range of concentrations of 6-
azauracil or 2-(4'-thiazoly)benzimidazole
(thiabendazole) allowed the determination of the most
suitable time of transfer and concentration of drug to
be used. Fusion products recovered using this
selection system were purified and analysed according
to the methods described for those obtained purely by
auxotrophic selection.
3.2.4 Assessment of Antibiotic Production.
The Pen Nand CPC titres of progeny from the
crosses were deter-mined by the plug assay or shake
flask fermentation methods described previously
(2 .2.4 .3 , 2.2.4 .4 and 2.2.4 .5 ). Where shake flask
fermentations were used, a Sabouraud slant culture of
\
each strain was grown and used to inoculate a seed
culture which in turn provided inoculum for three
replica fermentation flasks. When poss ible the
number of separate fermentation experiments necessary
to examine all of the progeny from a cross was
minimised to lessen the level of interference in the
resul ts due to environmental variation. Control
fermentations of the parental strains were carried out
simultaneously.
After bioassay of fermentation broths, and dry
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weight determinations on the mycelium, specific
potency (pg.antibiotic mg-l dry weight) values were
calculated for the progeny. A standard analysis of
variance (The Open University 1978) was performed to
determine to what degree the variation found between
the specific potencies of the progeny was due to
genetic differences rather than being due to
environmental effects. Where the number of progeny
obtained permitted, an estimation of the number of
effective factors (kl) segregating and influencing Pen
N or CPC titre was made according to the formulae
given in Table 3.1. Two methods of calculation are
possible and differ as to whether the parental mean
titres or the progeny extreme titres are taken into
account. The second of these alternatives is
considered to be the more reliable although it may
give a bias towards \a high value for kl. The mean
contribu·tion (d) of the effective factors could also
be determined. Where the alleles segregating in a
cross show additivity of action the mean titre of the
progeny should correspond with the mid-parental titre.
An expression of the divergence of the two means
could be calculated as i (Table 3.1) and this provided
a means'for the estimation of the degree of occurrence
of epistatic interactions. If there is no epistasis
the value of i should be zero, any deviation from zero
not accountable for by the limits of error of the
-112-
Table 3.1 Sta-t;isticalmethods
PI mean titre of parent 1
P2 mean titre of parent 2
VG genetic variance
fl progeny mean
Methods for the estimation of the numbers
of effective factors (k1) segregating and
affecting titre in a cross.
A
~1
B
4VG
(highest-lowest progeny titre)2
Methods for estimation of the mean
contribution (d) of effective factors
A d =
B d Highest-lowest progeny titre
Method for' calculation of
, estimate of epistatic interaction
i. an
i
to indicate epistasis i must be different
from zero either positively or negatively.
From: Burnett 1975
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calculations of the means, is indicative of epistatic
interactions.
3.2.5 Assessment of Titre Variation Amongst Single
Protoplast Isolates of Strain 20-2.1.
The amount of natural variability with respect to
titre, present in a culture of an antibiotic producing
strain and contributing to the variation in titre
amongst the progeny recovered following protoplast
fusion was examined. A protoplast suspension was
prepared from strain 20-2.1 and treated with PEG
according to the fusion protocol. After plating and
regeneration, a number of colonies were grown as
slant cultures. These were used to inoculate shake
flask fermentations and the absolute potencies of a
number of isolates of 20-2.1 were determined.
. I
3.3 Results.
A number of protoplast fusion crosses were
successfully carried out as described, and provided
progeny for. analys is: however, several problems were
encountered. Where one or more of the parental
auxotrophic requirements used for selection purposes
was leaky then a background of poorly growing colonies
could sometimes be s~en on fusion plates lacking such
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requirements. This could also aggravate problems
caused by cross-feeding of parental colonies resulting
in syntrophic growth. In such cases it was more
difficult to purify haploid selectants and to identify
possible heterozygous colonies. In the crosses
described below, only haploid-type fusion products
were studied.
3.3.1 Mapping Crosses for Auxotrophic Markers in
Strain 20-2.1.
Haploid recombinants were obtained on all of the
possible selective media in cross 1, 20-2.10 (leu-S
lys-2) x 20-2.17 (arg-8 ade-l) and cross 2, 20-2.11 (
leu-S met-8) x 20-2.17. Genetic analysis results for
these crosses are shown in Tables 3.2 and 3.3 and show
the free assortment of the markers involved except for
leu-S and met-8 which would appear to be linked
according to the data from cross 2. Examination of
the control plates suggested that the ade-l marker was
somewhat leaky and that some reversion of the met-8
marker may have occurred, although only isolated
revertants were seen.
Duririg the purification of
recombinants from both crosses
putative haploid
it was noticed that
where colonies were taken from media lacking adenine
the purification plates occasionally showed a range of
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Table 3.2Genetic analysis of haploid recombinants
recovered on selective media from
cross 1
20-2.10 (C0728 leu~5 lys-2) x 20-2.17
(C0728 arg-8 ade-l)
A. Pairwise Tables
leu ade lys arg
+ + + +
+ (23) 23 (8 ) 15
leu
13 (13) 11 (2 ) MM
+Leucine
+Arginine
+ (19 ) 12 ( 36) 19 (17)
ade
20 (3 )
MM + 39 (15 ) (31 ) 23 ( 19~ 17
+Leucine lys
+Adenine
+ (39 ) 15 31 (23) (54 )
arg
leu ade lys arg
+ + + +
+ (11 ) 6 ( 5 ) (9 ) 2
leu MM
+Lysine
+Arginine
+ (43 ) (6 ) 5 9 (2 )
MM ade
+Lysine 8 -e-
+Adenine
+ 21 (14 ) 7 ( 4 2
lys
(30 ) 29 (1 ) 5 (0 )
+ (51 ) 43 ( 8 ) (21 ) 30
arg
) indicates recombinant phenotypes
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Table 3.2 Continued
B. Phenotype analysis
Phenotypes Number on selective media
Leu Leu Lys Lys Total
leu lys arg ade Arg Ade Arg Ade
+ + + + 8 19 4 14 45
+ + + 11 12 23
+ + + 15 15
+ + 2 2
+ + + 20 7 27
+ + 3 3
+ + + 5 29 34
+ + + 2 2
+ + 1 1
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Table 3.3 Genet~c analysis of haploid recombinants
recovered on selective media from cross 2
20-2.ll (C072B leu-S met-B) x 20-2.l7
(C072B'arg-B ~)
A. Pairwise Tables
leu ade met arg
+ + + +
+ (39) 3 42 (42 )
leu
2 (0 ) (2 ) 2 MM
+Leucine
2 (41 ) 41
+Adenine
+ (23 )
ade
3 (3)
+ 23 (2) (25) (44 )
MM met
+Leucine
+Arginine
+ (17 ) 2 19 (19 )
arg
6 (0 ) ( 6 ) 6
leu ade met arg
+ + + +
+ (12) 11 (1) (B) 4
leu MM
+Methionine
+Arginine
+ (11 ) (11 ) 1 8 (4)
ade
MM 0
+Methionine
+Adenine
11 (11 ) 0 (8 ) 3+
met
(0 ) 0 (0) 0 (1 )
+ (11 ) 11 (0 ) (11 ) 0
arg
indicates recombinant phenotypes'
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Tab1e 3.3 Continued
B. Phenotype ana1ysis
Phenotypes Number on selective media
Leu Leu Met Met Total
leu met arg ade Arg Ade Ade Arg
+ + + + 17 39 11 8 75
+ + + 2 2 4
+ + + 6 3 9
+ + + 3 3
+ + 1 1
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colony types from large, quickly growing haploid types
.to small, slower growing colonies reminiscent of the
heterozygous colonies seen on fusion plates. On
further investigation most of these appeared to be the
results of the leaky growth of arg-8 ade-l auxotrophs.
An isolated case was found where after fragmentation
and plating onto YEA/Casamino acids medium a colony
gave rise to unstable colonies showing a range of
phenotypes with. abnormal morphologies and poss ible
areas of sectoring. This might suggest that the
original colony whilst resembling a haploid
recombinant was in fact heterozygous.
3.3.2 Sensitivity of Protoplasts to 6-azauracil and
thiabendazole.
Protoplasts prepared from strain 20-2.1 were plated
(106 per plate, with a viability of 4.7%) on
.cellophane discs on qSMM, and incubated. After
per iods of between 1 and 4 days the cellophane discs
were transferred onto a range of non-stabilized plates
which contained various concentrations of 6-azauracil
or thiabendazole, and further incubated. The degree
of regeneration and growth occurring under these
conditions is shown in Table 3.4. The transfer of
cellophane discs after 2 days to media containing
. -1
either 1 mg.ml 6-azauracil or 30uM thiabendazole
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were chosen as the most suitable conditions for use
for future selection purposes. Parental growth was
reduced to a faint background and did not interfere
with the de t ect Lon and purification of fusion
products. The regeneration of protoplasts prepared
from strains 20-2.33 (leu-5 met-8 tbz-2) and 20-2.34
(leu-5 met-8
confirmed.
azu-3) under these conditions was
3.3.3 Crosses Between Blocked Mutants and a Related
CPC Producing Strain.
Crosses were carried out between mutants impaired
in CPC bio-synthesis derived from strain 20-2.1 and a
marked strain 20-2.33 (leu-5 met-8 tbz-2) which
produced a good titre of CPC and had been derived from
the same progenitor strain as the blocked mutants.
The unavailability of auxotrophic markers in the
blocked strains, at the time of these experiments, led
to the use of thiabendazole as a selective agent
against the prototrophic blocked strains and selection
against the 20-2.33 parent by the omission of either
leucine or methionine from the regeneration plates.
Fig. 3~2 shows the effectiveness bf this as a
selection system.
Crosses involving strains 20- 2.29 (cnp-4) and 20-
2.27 (cnp-2) were successful in producing haploid
-122-
Fig. 3.2 Selection against parental strains in a pro-
toplast fusion cross by the use of auxo-
trophic and drug resistance markers.
A. Regeneration of 106 protoplasts of strain
20-2.33 (leu-5, met-8, tbz-2) on medium
supplemented with leucine methionine plus
30 m thiabendazole.
B.
6
Regeneration of 10 protoplasts of strain
20-2.27 (cnp-2) on minimal medium.
c.
6Selection against 10 protoplasts of strain
20-2.33 and strain 20-2.27 by plating on
medium supplemented with methionine plus
30 m thiabendazole.
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recombinant progeny (Table 3.5). Genetic analysis
revealed that the vast majority of the progeny
recovered on media supplemented with either leucine or
methionine were prototropic, thus supporting the
evidence in section 3.3.1 for the linkage of the leu-S
and met-8 genes (Table 3.6). The recovery of progeny
on either of the selective media, given the linkage of
these markers, is indicative of the non-linkage of the
tbz-2 marker to the two auxotrophic genes.
A preliminary screen of the antibiotic titres of a
number of the progeny from these crosses was carried
out using the plug assay system. Six PFM agar plugs
were inoculated for each strain, 3 to be assayed for
Pen Nand 3 for CPC production. Fig. 3.3 shows the
presence amongst the progeny of strains resembling
both of the parental types for cross 3 as well as
strains producing higher or lower titres of
antibiotic, and Fig. 3.4 shows the preliminary
results for cross 4. Shake flask fermentations of
the progeny allowed a more accurate determination of
antibiotic titre and gave the results shown in Figs.
3.5 and 3.6. Analysis of variance shows that a
considerable portion of the variation seen amongst the
progeny from both crosses, was genetic in origin
(Tables 3.7 and 3.8).
The recovery in both crosses of progeny showing
blocked and unimpaired CPC biosynthesis suggests that
· .
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Fig. 3.3 Distribution of antibiotic tit'res of
progeny from cross 3 as determined by plug
assay.
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Fig. 3.4 Distribution of antibiotic titres of
progeny from cross 4 as determined by plug
assay.
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Fig. 3.5 Distribution of antibiotic titres of the
progeny from cross 3. Shake flask
fermentation and bioassay data.
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Distribution of antibiotic titres of the
progeny from cross 4: Shake flask
fermentation and bioassay data
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Table 3.8 Analysis of variance for cross 4.
Variation Source Degrees of Mean Squares Variance
Freedom Ratio
Pen N Total 32 44951
Between progency 10 974.11
4.62*
Between replicas 22 211.06
CPC Total 32 26.49
Between progency 10 66.81
8.17*
Between replicas 22 817
*Significant atd..= 0.01
Pen N Genetic Variance (VG) = 44951-211.06 = 238.45
= 53.05% of total variance.
CPC Genetic Variance \VG) = 26.49 - 8.17 = 18.32
= 69.15% of total variance.
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there is no - linkage between the cnp-2 and cnp-4
mutations induced in strains 20-2.27 and 20-2.29 and
the leu-S, met-8 and tbz-2 markers. The small number
of progeny recovered from the cross between 20-2.33
and 20-2.27 would render further statistical analysis
unreliable, but estimations of the degree of epistasis
occurring and of the number and mean contributions of
the effective factors segregating in
involving 20-2.29 were made (Table 3.9).
the parental and progeny mean titres for
the cross
Comparing
the cross
between 20-2.33 and 20-2.29 it appeared that the
alleles segregating with respect to Pen N production
were mainly additive in effect. However, where CPC
production was concerned some epistatic interactions
are apparent with the progeny mean titre being
somewhat higher than that of the parental strains.
When values of, KI, the estimated number of
effec~ive factors affecting antibiotic production, are
calculated four assumpt~ons are made about the titre-
influencing alleles segregating in the cross. Thus
the alleles are (i) unlinked, (ii) of equal and
additive effect, (iii) not affected by epistatic
interactions and (iv) distributed such that all having
a positi~e effect occur in one parent and those having
a negative effect in the other. For this cross the
parents were deliberately chosen to minimize the
difference in their genetic backgrounds, i.e. only one
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of the mutations introduced was thought to
significantly affect titre. In view of this the
calculation of the Kl for Pen N would appear to be
valid.
Where CPC production is concerned the presence of
epistatic inter-actions complicates the situation
although the values of Kl are low suggesting the
presence of a small number of genetic differences
between the parental strains with regard to titre.
3.3.4 Titre Variation Amongst Sing1e Protop1ast
Iso1ates of Strain 20-2.1.
Protoplasts of strain 20-2.1 were taken through the
procedures involved in the PEG mediated fusion of C.
acremonium protoplasts and then allowed to regenerate.
Thirty nine isolates were then assayed by shake
flask fe'rrnerit a'tLon to determine their· absolute Pen N
and CPC potencies .Fig. 3.7 shows the spread of
titres found amongst the isolates and Table 3.10 gives
the results of an analysis of variance calculation on
the data obtained, and shows that the majority of the
observed variation was attributable to environmental
effects.
3.4. Discussion
Protoplast fusion crosses between the CPC producing
Fig. 3.7
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Distribution of antibiotic titres of
single protoplast isolates of strain 20-2.1
Mean
120.5 +/- 3.0
t
12
10
en
w
..... '
et
...I
80
!a
u.
0
a: 6w
tIl
~
:J
Z
4
2
16
14
12
10
en
w
~
...I
0 8!a
u.
0
a: 6w
m
s
:J
Z
4
2
I
60 100 12080 140 160
PEN N POTENCY 119,mg. dry weight-1
Mean
19.7 +/- 0.3
\
, .
I
I I
16. 18 2220 24 26
CPC POTENCY Ilg.mg. dry weight-1
-136-
Table 3.10 Analysis of variance for the antibiotic titres
of single protoplast isolates of strain 20-2.1
Variation Source Degrees of Mean Variance
Freedom Squares Ratio
Pen N Total 116 1061. 64
Between isolates 38 1509.39 1.79
Between replicas 78 843.50
CPC Total 116 11.25
Between isolates 38 11.53 1.04
Between replicas 78 11.12
Neither variance ratio is significant at ~ = 0.001
Pen N Genetic Variance (V~) = 1061.64 - 843.50
20.5 % of total variance
218.14
Environmental Variance = 79.4 % of total variance
CPC Genetic Variance (VG) = 11.25 - 11.12
1.195 % of total variance
0.13
Environmental variance = 92.8 % of total variance
-137-
strain 20-2.33 and two strains blocked in CPC
production have allowed the segregation of the mutant
alleles involved to be monitored. The free
assortment of these alleles with the markers used for
found with single
In comparison to the situation
protoplast isolates of the
selection was found.
progenitor strain 20-2.1 a substantial proportion of
the variation present amongst the progeny from both
these crosses with regard to titre could be ascribed
to genetic effects. The production of a trace level
of CPC by the blocked strain 20-2.27, previously shown
to be CPC negative, suggests though that it would have
been advisable for the variation in titre amongst the
progeny form both these crosses to have been compared
with that amongst single protoplast isolates of the
immediate parents to verify that the spread of titres
was pre-dominantly the result of recombination rather
than of strain variability.
Cross 3 involving 20:2.29 revealed the presence of
epistatic inter-actions with the progeny mean CPC
titre exceeding the mean parental value. The absence
of significant numbers of progeny carrying the leu-5
and met-8 alleles makes it impossible to determine
whether the increased CPC titre amongst the progeny is
due to the removal of epistatic titre reducing effects
resulting from the auxotrophies or other factors
associated with the linkage group carrying them.
-138-
These crosses also served to
potential use of drug resistance
marker and the plug assay system
investigate the
as a selectable
as a means of
determining the ~-lactam production characteristics of
progeny without recourse to large scale shake flask
fermentation experiments. A comparison of the data
obtained by plug assay with that from shake flask
experiments illustrates that both methods reveal the
same basic trends found amongst the progeny. The
data from plug assays is less accurate, with no
determination of qr owth. being taken into account and
with inoculum size being standardised only by eye.
However, the method has the advantage of allowing
large numbers of progeny to be screened relatively
rapidly and would be particularly useful in assaying
progeny from crosses designed to assess the presence
or absence of complementation between blocked strains.
The advantage of a selection strategy involving
drug resistance markers. may be seen in the use of
prototrophic strains in crosses. Since repeated
mutagenesis may in some cases lead to chromosomal
rearrangements and problems in obtaining recombination
between strains (MacDonald 1968) and since auxotrophic
markers may have pleiotropic effects on titre,
(MacDonald 1963), any means of reducing the number of
mutagenic steps prior to the use of a strain in a
fusion could prove of use.
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Sui table conditions for the application of either
6-azauracil or thiabendazole in selection were also
found, however,
the former
the level of spontaneous resistance to
led to the preferential use of
thiabendazole. Selection with 6-azauracil could be
feasible providing the level of spontaneous resistance
arising in the parental strains was very carefully
monitored.
Thiabendazole is a benzimidazole fungicide which,
in a similar manner to benomyl, interferes with the
process of mitosis by binding to tubulin and affecting
microtubule assembly and so may be used to induce the
genetic segregation of diploids. Studies have
suggested that segregation is induced primarily as a
resul t of the non-disj unction of chromosomes rather
than by a chromosome breakage and deletion mechanism
or by increasing mitotic crossing over (Kappas et al
1974; Kappas 1978; Davidse 1983).
The possibility that the frequency of mitotic
cross ing over is increased, cannot be excluded and a
comparison of the spectrum of progeny types obtained
from an C. acremonium fusion following selection with
thiabendazole with that obtained from the same fusion
following auxotrophic selection would be useful in
-detecting any bias in the genetic analysis as a result
of the· use· of the thiabendazole system. It would
also be of. interest to know the degree of dominance
-140-
shown by the tbz-2 gene following nuclear fusion.
Van Tuyl (1977) discussing the dominance of similar
mutations in A. nidulans, suggests that the degree of
dominance may vary considerably between different
resistance mutations. As the diploid stage of C.
acremonium is only transient (Hamlyn 1982) it is not
possible to determine the phenotypes of diploids
heterozygous or homozygous for tbz-2. However, the
successful selection of progeny from two crosses on
the basis of resistance to thiabendazole would suggest
that a sufficient expre?sion of the tbz-2 marker was
occurring at the time of transfer of the fusion
products to thiabendazole to allow both survival and
mitotic division.
Crosses designed to examine linkage relationships
between auxo- trophic markers present in strains
derived from 20-2.1 revealed the linkage of the leu-5
and met-8 markers in strain 20-2.33. The absence of
particularly
effects as
strong,
a result
.ple iotropic
of these
titre reducing
auxotrophies had
previously led to this strain being selected as the
most suitably marked parent strain for use in crosses
with the blocked mutants. However, the
linkage of the two auxotrophic markers presents a
problem. Selecti.on of fus ion products on media
lacking . either leucine or methionine will result in
the loss of the 20-2.33 linkage group concerned in the
-141-
vast majority of the progeny and consequently in the
loss of any alleles affecting titre positioned on the
same linkage group. Therefore were future mapping
work to be carried out, it would be beneficial for a
third unlinked auxotrophy to be introduced for use as
a selectable marker.
CHAPTER 4
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Complementation and Mapping Studies with Strains
Blocked in CPC Biosynthesis.
4.1. Introduction
The programme of mutagenesis described in Chapter 2
provided a number of mutant strains of C. acremonium
blocked for CPC bio-synthesis. In addition to these
several blocked mutants produced in other laboratories
from divergent strains of C. acremonium were available
in the Nottingham culture collection.
It was proposed to assess the complementation
relationships between the genes affected as a first
step towards the mapping of the mutations involved.
As heterokaryon formation is infrequent in C.
acremonium and the diploid stage is usually
considered to be tra~sient, (Nuesch et aI, 1973),
complementation between genes concerned cannot be
assessed by determining the CPC biosynthetic capacity
of diploids formed between pairs of the mutants.
Therefore, the examination of the CPC titre of haploid
segregants obtained following protoplast fusion
crosses is necessary for complementation analysis.
In addition to providing data allowing the allocation
of mutations affecting titre to complementation groups
such studies would necessarily also provide
information regarding the presence or absence of
-143-
linkage between the titre affecting mutations and the
selectable markers introduced into the parental
strains as a pre-requisite for protoplast fusion
crosses.
4.2 Materials and Methods.
Descriptions of the strains used, with two
exceptions can be found in Chapter 2. Strain 20-3.5
(nic-l) was derived by U.V. mutagenesis from strain
20-3.2 (M-40) a blocked mutant deficient in the
conversion of DAC into CPC and was kindly provided by
Takeda Research Laboratories, Japan. Strain 20-5.2
(M8650-~--M26-127a/2) required a reduced or organic
source of sulphur for growth, carried a leaky mutation
blocking the hydroxylation of DAOC to DAC and was
kindly supplied by Dr. H. J. Treichler of Ciba
Geigy, Basel, Switzerland.
The procedures used for the isolation and fusion of
protoplasts and for the selection of recombinant
progeny were generally as described in Chapter 3.
Following crosses 9-12 a number of progeny were
recovered after the fusion mix, diluted 1 part to 3
with osmotic stabilizer, had been plated directly onto
cellophane discs on OSMM plates without the prior
removal of the PEG present. Titre analysis of the
progeny was carried out either by the plug assay or
-144-
the shake flask fermentation methods described in
Chapter 2.
4.3 Results
Eight crosses between pairs of mutants were carried
out (Table 4.1). Recombinant progeny were recovered
from all of the crosses. Fusions 8, 9 and 10 yielded
somewhat unusual fusion products which, whilst
resembling haploid recombinants in their appearance,
on purification behaved in a manner reminiscent of
that of heterozygous fusion products. A more
stringent purification system was adopted in order to
obtain stable haploid progeny from these crosses.
4.3.1 Cross 5. 20-3.4 (cnp-7 leu-4) x 20-5.2
A number of haploid pr9geny were obtained from this
cross by selection on MM.
strains (20-3.4) produced
progeny
As one of the parental
the yellow pigment,
were scored for itschrysogenin, the
production as a non-selective marker. Chrysogenin
production' did not show linkage to either the S or
fhe leu-4 markers with 29 out of 59 progeny producing
the pigment. Bioassay of shake flask fermentation
broths showed the range of Pen N titres occurring
-145-
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amongst the progeny (Fig. 4.1) and an analysis of
variance demonstrated the genetic as opposed to
environmental basis of the differences in titre seen
(Table 4.2). Strain 20-5.2 was reputed to produce
. -1 -1
approximately 900 pg.ml of Pen Nand 100-300 ug.ml
of DAOC but under the conditions used in this work it
-1gave a titre averaging only 84 pg.ml Pen N despite
showing good growth characteristics. HPLC analysis
of fermentation broths demonstrated the presence of
both parental types with regard to titre amongst the
progeny, suggesting that the leu-2, cnp-7 and ~-, cnp-
.!! pairs of loci are not linked. Isolated strains
with increased production of Pen N were also obtained
but none of the progeny showed the ability to produce
CPC. Recombinant progeny carrying both the mutant
cnp-7 and cnp-8 alleles if present would be expected
to be indistinguishable on the grounds of titre, from
progeny ,carrying the cnp-7 ,allele alone.
Recombinants wild-type for both the alleles, would on
the other hand be expected to be recovered as CPC
producers since the parental strains were impaired in
different steps of the CPC biosynthetic pathway. A
variety of explanations are possible as to the.absence
of CPC producing recombinants amongst the progeny.
The parental strains involved had been derived from
divergent strain improvement lines and could therefore
have carried chromosomal rearrangements which may have
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Table 4.2 Analysis of variance for Pen N titre of
progeny from cross 5
Variation
Source
Degrees of
Freedom
Mean Variance
Ratio
Total 176 7.46
Between progeny 58 22.02 73.21*
Between replicas 118 0.3007
Genetic Variance (VG) = 95.97% of total variation
* Significant at ~ = 0.01
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given rise. to difficulties in recombination between
them and resulted in a loss of viability of or
selection against some recombinant types.
Alternatively, if cnp-7 and cnp-8 are linked, then
mitotic recombination would have been necessary to
yield strains producing CPC. However, the number of
progeny obtained could have precluded the detection of
such events. Linkage between the cnp-7 and ~ or the
cnp-8 and leu-4 loci would also give rise to progeny
predominantly of parental types with respect to titre.
Further investigati9n of these possibilities would
require the introduction of selectable markers into
the strains to allow progeny carrying the linkage
groups marked by the leu-4 and S alleles to be
recovered.
4.3.2 Cross 6. 20-3.4 (cnp-7 leu-4) x 20.3.5
(cnp-9 nic-l)
The leaky nature of the nicotinic acid requirement
of strain 20-3.5 led to problems in the selection and
recovery of progeny from this sister strain cross.
Shake flask fermentations of the 9 prototrophs
obtained showed 5 to be completely negative for )3-
lactam production, and 2 to resemble the 20-3.5 parent
in producing a high Pen N but low CPC titre. Strain
20-3.4 whilst classified as negative for Pen N
-150-
production, always gave fermentation broths which
produced very small inhibition zones when assayed
against Sarcina lutea ATCC 9341. It is notable that
the 5 non-producing progeny did not produce even this
slight inhibition and so were not completely identical
to strain 20-3.4 in phenotype. The remaining 2
progeny produced a lowered total B-lactam yield than
strain 20-3.5 but showed a higher ratio of CPC:Pen N
production (Fig. 4.2) HPLC analysis of fermentation
broths revealed that these latter strains did not
accumulate DAC to the same degree as the parent 20-3.5
(Fig. 4.3), suggesting that some restoration of acetyl
CoA deacetylcephalosporin C O-acetyltransferase
activity may have occurred. The recovery of strains
which yielded parental type titres and of strains with
improved abilities to convert DAC into CPC might
suggest that the cnp-7 and cnp-9 alleles were
segregating freely in this cross, with respect to each
other and to the leu~4 and nic-l markers.
4.3.3 Cross 7.
(~ cnp-8).
20-3.5 (cnp-9 nic-l) x 20-5.2
Problems associated with the leaky growth of strain
20-3.5 on fusion plates led to the recovery of only 4
prototrophic progeny from this cross. These had the
antibiotic titre characteristics shown in Fig. 4.4.
Fig. 4.2
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Distribution of antibiotic titres amongst
progeny recovered from cross 6.
1 3 20-3.520.'3.484 6 7 5
PROGENY NUMBER
2 9
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Fig. 4.3 H.P.L.C. analysis of cross 6, 20-3.4
(cnp-7) (leu-4) x 20-3.5 (cnp-9 nic=-l)
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Fig. 4. 3
(cont)
Distribution of antibiotic titres amongst
progeny recovered from cross 7.
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Distribution of antibiotic titres amongst
progeny recovered from cross 7.
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Two progeny strains (numbers I and 3) resembled the
20-3.5 parent strain in producing low levels of CPC,
however, their Pen N titres were reduced in comparison
to the parent. The remaining two strains both had
titre characteristics similar to the other parent, 20-
5.2. However, one of these (number 2 in Fig. 4.4)
showed enhanced Pen N production. HPLC profiles of
the strains were compared (Fig. 4.5) and revealed that
where the progeny appeared to resemble the parental
strains on the basis of the bioassay data, the pattern
of accumulation o~ CPC biosynthetic intermediates
could vary, hence progeny numbers 2 and 4 showed the
accumulation of DAC apparently at the expense of DAOC.
Taken as a whole the results are indicative of the
occurrence of some recombination with respect to genes
affecting ,B-Iactam production. The extent to which
this particularly concerned the cnp-8 and cnp-9
aJ"leles cannot be determined. The divergent nature
of the parental ~trains may have contributed a
considerable level of background variation in titre to
the cross.
4.3.4 Cross 8 20-3.10 (cnp-7 leu-4 tbz-6) x 20-2.32
(cnp-5),Cross 9 20-3.11 (cnp-7 leu-4 his-2)x 20-2.42
(cnp-S orn-I)
Crosses 8 and 9 were carried out to test for
-156-
Fig. 4.5 H.P.L.C. analysis of cross 7.
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complementqtion between cnp-5 and cnp-7.
Biochemically these mutations result in a decrease in
the activity of isopenicillin N synthetase (IPNS).
Both strain 20-3.1, the progenitor of strain 20-3.10,
and a single colony isolate of strain 20-2.32 showed
negligible IPNS activity on assay. However, the
phenotype of strain 20-2.32 would appear to be not as
stable as that of the other parental strain and on
subculturing some B-lactam production occurred, so
that when isolated following mutagenesis of strain 20-
2.32, strain 20-2.4~ was found to produce Pen N.
Progeny
basis of
were selected following cross 8 on the
uMprototrophy and resistance to 30
thiabendazole. Only a small number of colonies were
recovered from the fusion plates and these only after
prolonged incubation. Seven of the isolates
resembled haploid recombinants in their behaviour on
puzLfi.cet Lon and showed segregation witl: respect to
the presence of chrysogenin, which is produced by 20-
3.10 but not by the other parental strain. A further
3 colonies were examined which on purification gave a
mixture of colony types. In two cases these had
shown the presence of sectors on the original fusion
plates. The results of the analysis of one of these
putative fusion products are given in Fig. 4.6 and
suggest that the original sectoring colony did possess
areas of growth of a recombinant phenotype although
-158-
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the 20-3.10 parental phenotype could still be
recovered from the central region of the colony.
Further analysis of this cross was not undertaken
partly because of the unusual length of time taken for
the growth of the fusion products but mainly because
the low number of progeny obtained indicated the
necessity of repeating the cross in order to obtain
sufficient numbers of recombinants for the
complementation analysis of cnp-5 and cnp-7.
Following the introduction of additional
auxotrophic markers into the two strains, used in
cross 8 (see Fig. 2.5) to give strains 20-3.11 and 20-
2.42, a further cross (cross 9) was performed.
Presumptive haploid fusion products were recovered on
media supplemented with either leucine or histidine.
Fig. 4.7. On purification many of the progeny
yielded heterogeneous populations of colonies which
\
varied with respect to morphology and to chrysogenin
production and wpich in turn gave further
heterogeneous populations on purification (Fig. 4.8).
It would appear that certainly for a proportion of the
colonies the process of non-disjunction thought to
follow relatively rapidly after diploid formation in
c. acremonium had not been completed to give solely
haploid recombinants. To assist in the recovery of
progeny from the incompletely broken down fusion
products a strategy of further purification was
Fig. 4.7
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Fusion products recovered from Cross 9.

Fig. 4.8
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Examples of the heterogeneity observed
during the purification of fusion products
recovered from Cross 9 on MM + histidine
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employed according to the scheme shown in Fig. 4.9.
In order to avoid clonal effects, only one randomly
chosen representative colony per original fusion
product was selected following each round of
purification. A low level of the fungicide
thiabendazole (15-20MM) was included in the second
stage purification plates but did not appear to result
in a dramatic increase in the numbers of homogeneous
colony types isolated in subsequent stages. After
two rounds of purification on selective media to
eliminate any syntrQphically growing parental colonies
the purification was continued on YEA/Casamino acids
medium to allow the recovery of samples of all
recombinant types arising from the 'heterozygous'
fusion products. During purification many aberrant
morphological types were seen (Fig. 4.10). These
colonies were often still unstable and gave mixed
populations on pur i.f Lcat Lon , In some cases these
.coLonLes (Fig. 4 .ll) resembled in appearance the
'stable heterozygote' described by Perez-Martinez
(1984).
By comparison with A. nidulans where colonies
aneuploid for specific linkage groups show specific
morphologies (Upshall, 1971) it might be suggested
that the range of aberrant morphologies observed
amongst the products of this cross could represent
specific aneuploid states in C. acremonium, however,
-163-
Fig. 4.9 Purification schere far progeny isolated fol.l.cw.ing cross 9
Fusion products
on selective media (SM)
I
Colonies purified on SM
Harogeneous
populations of colonies
I
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Example of. aberrant morphological colony
types observed during purification of
progeny from cross 9 on YEA/Cas medium.

Fig. 4.11
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Co1ony resemb1ing the 'stab1e
heterozygote' described by Perez-
Martinez (1984)
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the lack of-sufficient genetic markers in the parental
strains did not permit this possibility to be
investigated.
The unusual persj,stence of colonies which
segregated to give mixed populations on purification
and the requirement for as large a number of haploid
progeny as possible from cross 9 led to the necessity
of defining at which stage colonies would be accepted
as being stable haploids suitable for phenotype
analysis. The use of DNA estimations to determine
ploidy was not feasible due to the large numbers of
colonies which would have required screening and the
difficulty frequently found in obtaining sufficient
numbers of conidia. It is also unlikely that such
estimations of ploidy would have been completely
reliable in distinguishing haploids from colonies
aneuploid for a small numnber of linkage groups.
\
Therefore .throughout the purification procedure
isolates which gave morphologically homogeneous
populations of colonies, with no visible evidence of
sectoring on two consecutive purifications were taken
as stable haploids and their phenotypes analysed.
This approach though did not guarantee the haploid
nature of the colonies selected. In many cases the
colonies reaching this stage resembled morphologically
one or other of the parental strains.
The number of progeny originating from the two
-167-
selective media which were taken for analysis from the
different stages of
shown in Fig. 4.9.
the purification procedure is
In view of their different
origins the strains were designated into groups I, II
and III. During analysis the progeny from these
three groups were considered separately to allow the
detection of any changes in the phenotypes being
selected at the different stages of purification.
Pairwise data for the groups can be found in Table
4.3, with Table 4.4 showing a summary of the
distribution of the phenotypes found.
As the selection pressure was relaxed by allowing
haploidization to continue on YEAjCasamino acids
medium the recovery of alleles previously selected
against shows their persistence amongst the fusion
products through several selection stages. The poor
recovery of the leu-4 wildtype allele on MM
supplemented with leucine could be indicative of a
selective advantage associated with the leu-4 allele
under the given circumstances. There is little clear
and consistent evidence for linkage between the
auxotrophic markers involved in the cross. Data on
progeny derived from
shows the possibility
orn-l but this is not
MM supplemented with leucine
of linkage between leu-4 and
apparent amongst the progeny
derived from MM supplemented with histidine. Like-
wise data for group III isolates from MM plus leucine
-168-
Table 4.3
Pairwise analysis of progeny recovered following cross 9
(A) progeny originally recovered on MM+ leucine
Group I Purified on MM+ leucine
orn his CPC Chy
+ + + +
+ ( 0 ) 0 0 0 0 0
leu
30 ( 30 ) - 4 26 5 25
+ 5 5 0 5
chy
26 26 4 21
Group II Purified on MM + leucine + thiabendazole
orn his CPC Chy
+ + + +
+ ( 0 ) 0 0 0 0 ·0
leu
14 14 3 11 6 ( 8 )
Chy + 6 6 0 6
8 8 3 5
Group III Purified on MM+ leucine + thiabendazole and
subsequently on YEA/Cas
orn his leu chy CPC*
+ + + + +
+ ( 3 ) 30 ( 3 ) 30 6 ( 27 ) ( 5 ) 26
orn
0 ( 0 ) 0 ( 0 ) ( 0 ) 0 ( 0) 0
+ 3 ( 0 ) (0 ) 3 ( 0 ) 3
his
(0 ) 30 6 ( 24 ) ( 5 ) 23
+ ( 0 ) 3 ( 0 ) 3
leu
6 ( 25) ( 5 ) 23
+ (0 ) 6
chy
(5 ) 20
*Antibiotic titre was assessed for 31 of the 33 progeny
recovered.
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Table 4.3 continued
(B) Progeny Originally Recovered on MM+ Histidine
Group I Purified on MM + histidine
leu orn CPC chy
+ + + +
+ 23 ( 23 ) ( 19 ) 4 ( 0 ) 23
his
( 2 ) 2 ( 0 ) 2 0 ( 2 )
+ 0 0 0 0
chy
25 25 19 6
Group II Purified on MM + histidine + thiabendazole
leu orn CPC -chy
+ + + +
+ 0 ( 0 ) ( 0 ) 0 ( 0 ) 0
his
( 3 ) 3 ( 0 ) 3 0 ( 3 )
+ 0 0 0 0
chy
3 3 0 3
Group III Purified on MM + histidine + thiabendazole and
subsequently on YEA/Cas
orn his leu chy CPC*
+ + + + +
+ ( 5 ) 21 (12) 14 4 ( 22) ( 2 ) 20
orn
0 ( 2 ) 1 (1 ) (0 ) 2 ( 0 ) 1
+ 5 ( 0 ) ( 1) 4 ( 2 ) 3
his
(8 ) 15 3 (20 ) (0 ) 18
+ (2 ) 11 ( 2 ) 8
leu
2 ( 13 ) ( 0 ) 13
+ (1 ) 2
chy
( 1) 19
denotes recombinants
* Antibiotic titre was assessed for 23 of the 28 progeny
recovered.
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Table 4.4 Phenotype analysis for cross 9
A. Phenotype analysis of progeny origina·lly selected
on MM s~pplemented with leucine
Phenotype Distribution Amongst
progeny groups
leu chy* his orn CPC** I II III Total
+ + 21 5 26
+ + + 4 3 7
+ + + 5 6 11
+ 17 17
+ + 6 6
+ + 5 5
+ + + 3 3
Overall CPC +/- ratio 12: 63
B. Phenotype analysis of progeny originally selected in
MM supplemented with histidine
Phenotype Distribution amongst
progeny groups
leu chy* his orn CPC**
+ + + i
+ + +
+ +
+
+ +
I
19
4
2 3
III
1
3
5
10
2
1
1
Total
20
7·
10
10
2
1
1
II
+ + + + +
Overall CPC +/- ratio 21: 29
* =/- denotes presence/absence of chrysogenin
**+/- denotes production/non-production of CPC
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suggests linkage of leu-4 and his-2 but this is not
consistent throughout all of the data available.
Progeny were tested for antibiotic production by
plug assay, two plugs being assayed for Pen N and two
for CPC production per isolate. A number of
regenerant colonies from proto-plasts of the parental
strains were assayed as controls. In a small number
of cases progeny failed to give consistent assay
results and consequently.were omitted from the data.
Plug assay results were considered primarily of being
indicative of eithe~ CPC production or non-production.
Evidence for the complementation of cnp-5 and cnp-7
was found amongst the progeny from both selective
media used (Table 4.4). The numbers of CPC producing
progeny recovered, suggest that is unlikely that cnp-5
and cnp-7 are allelic. Two non-allelic gene
differences resulting in impaired CPC biosynthesis
would be expected on segregation to give progeny
producing CPC in a. ratio of 1:3 producers to non-
producers providing that there was no linkage between
the genes and the selectable markers involved in the
cross. This ratio is not found amongst the progeny
isolated from either selective media. Progeny from
MM plus histidine show a ratio close to 1:1 regarding
CPC production contrasting with the situation amongst
the progeny obtained from MM supplemented with leucine
where an excess of CPC non-producers is seen. The
-172-
approximately 1:1 ratio on MM plus histidine could be
explained by the linkage of either cnp-5 and orn-l or
cnp-7 and leu-4 resulting in the selective loss of one
of the alleles adversely affecting CPC biosynthesis.
Neither of these linkages are consistent with the data
derived from progeny selected on MM plus leucine and
the significance of the different ratios found with
the two selective media remains unclear.
The distribution of Pen Nand CPC titre amongst the
progeny was also considered. Fig 4.12 shows a
summary of progeny _titres assessed in terms of the
mean diameter of the zones of inhibition which were
produced on bioassay. A breakdown of the titre
distributions showing the contribution made by the
different groups of progeny is shown in Appendix II.
Detailed statistical analysis of the variability in
titre shown was not carried out due to the lack of
more accurate shake flask fermentation data. Progeny
with cnp phenotype~ resembling both parents were
obtained in addition to those which show restored CPC
production. A further group failed to produce even
the small zone of inhibition typical of parent 20-
3.11, when assayed against Sarcina lutea ATCC 9341.
The majority of progeny falling into this category
were isolated in group III after subculturing on
YEA/Casamino acids medium and prolonged purification.
-173-
A. Pen N
Distribution of antibiotic titres
amongst progeny recovered from ~ross 9
Progeny recovered on MM + histidine
Fig. 4.12
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Fig. 4.1.2 Continued
B. Progeny recovered on MM + leucine
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4.3.5 Cross 10 .20-3.11(cnp-7 1eu-4 his-2) x 20-2.43
(cnp-6 met-13).
The strains concerned in this cross differed
phenotypically with respect to CPC biosynthesis: 20-
3.11 being deficient in the production of
isopenicillin N and strain 20-2.43 appearing to be
impaired in the conversion of Pen N into DAOC.
Fusion products were selected on MMsupplemented with
either leucine or histidine. On purification the
behaviour of the pr'esumptLve haploid fusion products
resembled those recovered from cross 9 in producing
heterogeneous populations of colonies. These were
purified according to the protocol described
previously and the numbers of progeny selected after
the different stages of purification are shown in Fig.
4.13. Phenotype analysis was carried out, again
keeping the results from the different groups of
progeny separate and using the plug assay method to
determine antibiotic titres.
Table 4.5 shows the pairwise analysis for this
cross with Table 4.6 showing a summary of the
phenotypes recovered at the different stages of the
purification procedure. Much of the data suggests
free assortment between the auxotrophic and the
chrysogenin markers, although some indication of
linkage 'between his-2 and chrysogenin production is
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Fig. 4.13 Purification schsne for progeny isolated fol..low:ing ~ 10
Fusion products
on selective media (91)
I
Colonies. purified on 91
Harogeneous
p:>pulations of colonies
I
Purification on
YEA/casmediun
. J
Master plate
inoculated
I
Genetic analysis
PROGENY GROUP 1
Original srn NUl'ber of
progeny
recovered
M1+leucine 0
Heterogeneous
p:>pulations of colonies
I
Purification on SM+
thic:ibendazole
I
I
Heterogeneous
p:>pulations of colonies
I
Purification on
YEA/Casmedium
Purification
. on YEA/Cas
nediun
,----Master plate· Heterogeneous
inoculated
I
Genetic
analysis
I
PROGENY
GROUP III
Original 91 Nunber of
Harogeneous
p:>pulations of colonies
I
Purification on
YEA/casmedium
I
Master plate
inoculated
I
Genetic lanalYSis
PROGENY GROUP II
Original srn Nunber of
progeny
recovered
M1+leucine 6
MM+histidine 30
Heterogeneous
populations of colonies
I
Purification on
YEA/casmedium
/~
Harogeneous Heterogeneous
progeny
recovered
M1+leucine 25
l>fo1+his tidine 29
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Table 4.5 Pairwise analysis of progeny recovered
following cross 10
(A) Progeny originally recovered on MM + leucine
Group II Purified on MM + leucine + thiabendazole
CPC chy his met
+ + + +
+ 1 1 ( 0 ) 2 2 (2 )
leu
o 4 4 (0) ( 4 ) 4
Group III Purified on MM + leucine + thiabendazole and
subsequently on YEA/Cas
leu his met chy CPC*
+ + + + +
+ 11 (3 ) (13 ) 1 (2) 12 4 7
leu
( 8) - 3 10 (1) 1 (10) 0 8
+ (19 ) 0 (2 ) 17 4 12
his
4 (2) 1 ( 5 ) 0 3
+ 2 (21) 4 14
met
( 1) 1 0 1
+ 1 2
chy
3 13
*
denotes recombinants
Antibiotic titre was assessed for 19 of the 25 progeny
recovered
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Table 4.5 Continued
(B) Progeny originally recovered on MM +histidine
Group II Purified on MM + h±stidine + thiabendazole
leu his met
.chy CPC*
+ + + + +
+ 19 (ll) (30) 0 (10) 20 2 21leu
+ (l9 ) (0 ) 19 2 12his
II 10 ( 1) 0
(20) 2
9
10 21
met
+ o 8
chy
2 13
Group III Purified on MM + histidine + thiabendazole and
subsequently on YEA/Cas
leu his met chy CPC**
+ + + +' +
+ 14 ( 8 ) (20 ) 2 (3 ) 19 3 12
leu
(3 ) 4 7 ( 0 ) 1 ( 6 ) 1 6
+ (17 ) 0 ( 3 ) 14 4 12
his
10 ( 2 ) 1 (11 ) 0 6
+ 4 (23 ) 4 18
met
(0 ) 2 0 0
+ 3 1
chy 1 17
* antibiotic titre was assessed for 23 of the 30 progeny
recovered
** antibiotic titre was assessed for 22 of the 19 progeny
recovered
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Table 4.6 Phenotype analysis for cross 10
A. Phenotype analysis of progeny originally selected
on MM supplemented with'leucine
leu
Phenotype
his met chy CPC
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+ +
+
Overall CPC +/- ratio
Group I Group II
MM+leu MM+leu
TBZ
1
1
4
5 20
GroupIII
MM+ leu
TBZ
YCH
3
5
1
1
1
7
1
Phenotype analysis of progeny originally
on MM supplemented with histidine
MM+his MM+his
Group I TBZ
B.
GroupII
Phenotype
leu his met chy CPC
+ + + 12
+ + + + 2
+ + + 8
+ + 1
+ + + + +
+
+ +
+ +
+ + +
Overall CPC+/- ratio ,6: 39
MM+his
TBZ
YCH
GroupIII
10
2
3
3
2
1
1
Total
4
6
5
1
1
7
1
selected
Total
22
2
8
3
3
3
2
1
1
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given by the results for group II progeny selected
from MM plus histidine. However, this is not
substantiated amongst the other progeny groups.
Examination of the variation in Pen Nand CPC titres
amongst the progeny reveals that the titre character-
istics of both parental strains were recovered amongst
the progeny (Fig. 4.14 and Appendix III). A group of
recombinants which on assay produced less inhibition
of Sarcina lutea ATCC 9341 than the 20-3.11 parent
were also recovered, showing similarity with a group
of progeny from Cross 9. CPC producing recombinants
were found showing the complementation of cnp-6 and
cnp-7. The numbers of CPC producers from both
selective media were low, falling below the level
expected if two unlinked genes were segregating
freely. However, there is no strong case for linkage
shown in the data. The low recovery of CPC producers
could -then be a reflection of differences in the
selective advantage or disadvantage of certain
phenotypes under the conditions of this fusion. An
understanding of factors which could result in bias
amongst the progeny recovered could only be gained as
further crosses involving the parental strains were
examined to reveal any trends in the types of progeny
recovered.
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Fig. 4.l.4 Distribution of antibiotic titre amongst
progeny recovered from cross l.0
A. Progeny recovered on MM + histidine
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Continued
Progeny recovered on MM + leucine
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4.3.6 Cross 11 20-2.42 (cnp-5 orn-1) X 20-2.43
(cnp-6 met-13).
Putative haploid progeny were recovered on MM
following this fusion. On purification a tendency to
produce heterogeneous populations of colonies was seen
but the problem was not as severe as amongst the
progeny of crosses 9 and 10. Of the 57 prototrophic
progeny finally obtained, 37 appeared stable following
the first purification on MM and the remaining 20 were
isolated after a second round of purification on MM
supplemented with 15-20 pM thiabendazole. These were
assessed for B-lactam production by plug assay giving
the results presented in Fig. 4.15. Over half of the
progeny (32 out of 57) tested were CPC producers,
showing the cnp-5 and cnp-6 mutations to be
complementary. Nei ther of the wild- type alleles of
the cnp-5 and cnp-6 markers had been lost as a result
of the selection against the linkage groups carrying
met-13 and orn-l. The higher number of CPC producing
progeny obtained would suggest that cnp-5 and cnp-6
are not linked and could also be indicative of linkage
between either cnp-5 and orn-l or cnp-6 and met-13.
Further investigations of these possibilities would
require the introduction of further selectable markers
into the parental strains to allow the recovery and
study of progeny carrying the orn-l or met-13 markers.
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Fig. 4.15 Distribution of antibiotic titres amongst
progeny recovered fr~m cross 11.
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4.3.7 Cross 12 20-2.44 (cnp-1 ino-2) x 20-2.49
(cnp-6 met-13 tbz-9)
The markers present in the parental strains used in
this fusion allowed the selection of possible haploid
recombinants on either MM or MM supplemented with
inos itol plus 30}.lM thiabendazole. Selectants were
obtained on both media. This proved to be a more
typical cross and the problems due to heterogeneity of
fusion products described previously did not arise.
Progeny were analysed with respect to the relevant
non-selective marker for the selection system used and
for ~-lactam production. Table 4.7 give& the
distribution of phenotypes recovered and Fig. 4.16
illustrates the distribution of titres found amongst
the progeny. There was no indication of linkage
between the met-13, tbz-9 and ino-2 markers. The low
recovery of ino-2+ tbz-9+ colonies on MM could be
indicative of linkage but it is not consistent with
the recovery of considerable numbers of progeny
carrying the ino-2 marker on MM supplemented with
inos itol and thiabendazole. For progeny obtained
from both selection systems the range of Pen N titres
found spans the titres of both the parental strains.
In both cases a number of CPC producers were isolated
although the level of restored production was
decreased compared to the production of CPC by the 20-
-186-
Table 4.7 Phenotype analysis for cross 12
A. Phenotype analysis of progeny recovered on MM
Phenotype Number
met ino TBZ* CPC*
+ + + 4
+ + + + 2
+ + 71
+ + + 5
82
Ratio CPC +/- = 7:75
B. Phenotype analysis of progeny recovered on MM
+ inositol + thiabendazole
Phenotype No.
met ino TBZ* CPC*
+ + 61
+ 17
+ + + 4
+ + 23
105
Ratio CPC +/- + 27:78
* + = wild type i.e. sensitive to thiabendazole
or CPC producing
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Distribution of antibiotic titres amongst
progeny recovered from Cross 12
Progeny recovered on MM
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ContinuedFig. 4.16
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2.1 controls. That CPC production at any level
should be restored is of interest since both the
parental strains were deficient in the conversion of
Pen N into DAOC. The ratio of CPC producers to non-
producers isolated from MM supplemented with inositol
plus thiabendazole suggests that cnp-l and cnp-6 are
non-allelic and unlinked either to each other or to
tbz-9 or met-13.
In contrast a lower ratio of producers to non-
producers was found amongst the progeny obtained by
selection on MM. _ Linkage of cnp-6 to the wild-type
allele of ino-2 could be one explanation for this,
with the num. ber of inositol independent progeny
competent to produce CPC being low (8.5% of the
progeny selected on MM and 3.8% of those selected on
MM plus inositol and thiabendazole) and with similar
numbers of inos itol requiring CPC producers and non-
\
producers being recovered. However, it is possible
that the difference in numbers of CPC producing
progeny recovered could be the result of the
differential survival of recombinant types under the
two selection systems used.
4.4 Discussion
A number of C. acremonium strains carrying
mutations having major effects on CPC biosynthesis
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were used- in protoplast fusion crosses designed to
test the complementary nature of the mutations
involved. Not all possible pairs of mutations were
examined because of the time scale involved, however,
a representative group of tests were carried out.
Progeny were examined primarily to determine their
ability or lack of ability to synthesise CPC with the
quantitative aspects of the analysis being of
secondary concern. In a number of cases, this led to
the use of a plug assay system as a means of
evaluation of ~-lactam titre. The plug assay method
facilitated the screening of larger numbers of progeny
per given period of time than would have been possible
had shake flask fermentations been used. Results of
crosses described in Chapter 3 suggested the system to
be reasonably reliable in giving a profile of the
spectrum of ~-lactam titres found amongst the progeny
\
of a. cross. The system is .not as satisfactory
though for providing data for quantitative analysis in
that no measure of growth is taken into account and
absolute potency values cannot be calculated for the
progeny. Neither is the detailed analysis of
fermentation broths by HPLC which was of use in
crosses 5, 6 and 7 possible. Ideally shake flask
fermentations would have been carried out on the
progeny from all of the crosses to allow the data
regarding antibiotic titre obtained to be processed to
-191-
examine the statistical evidence for or against the
linkage of factors affecting titre and other markers
present.
Complementation to give CPCprogeny was observed in
the majority of crosses (Table 4.8). The results of
three crosses (5 , 6 and 7) were more difficul tto
interpret. Because of the leaky nature of the nic-l
marker, only a very small number of progeny was
obtained in crosses 6 and 7. The failure to observe
recombination in cross 5 to yield CPC. producing
progeny, des pi te -the nature of the biochemical
differences of the parental strains suggesting that
this should have been possible, was also a reflection
of the number of progeny obtained.
sufficient to either confirm or
This was not
eliminate the
possibility of linkage between the two mutated CPC
genes. In the ,case of linkage the recovery of CPC
producing progeny would be the consequence of mitotic
recombination. The results of cross 9 showed that
recombination between strain carrying cnp-5 and cnp-7
gave progeny with a restored capacity to synthesise
CPC. Earlier biochemical evidence had suggested that
mutations cnp-5 and cnp-7 both resulted in impaired
IPNS activity although the phenotype conferred by cnp-
7 appeared stable whilst the strain carrying cnp-5
showed a tendency to possess IPNS activity on
subcul turing. Genetic results indicate that cnp-5
-192-
Table 4.8 Complementation between C. acremonium
strains carrying mutations resulting 1n
impaired CPC biosynthesis.
Cross 1. Parental cnp mutations Presence/Absence (+/-)
strains present of compJ,ementation
? denotes results
inconclusive
20-3.4 cnp-7
5 ?
20-5.2 cnp-8
20-3.4 cnp-7
6 ?
20-3.5 cnp-9
20-3.5 cnp-9
7 ?
20-5.2 cnp-8
20-3.10 cnp-7
8 ?
20-2.32 cnp-5
20-3.11 cnp-7
9 +
20-2.42 cnp-5
20-3.11 cnp-7
10 +
20-2.43' cnp-6
20-2.43 cnp-6
11 +
20-2.42 cnp-5
20-2.49 cnp-6
12 +
20-2.44 cnp-1
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and cnp-7· are not allelic and the frequency of CPC
producing recombinants recovered from MM supplemented
with histidine also suggests that they may not be
located on the same linkage group. Ramos et al
(1986) proposed that the mutation resulting in the
loss of CPC production carried by strain N-2 (20-3.1)
the progenitor of 20-3.11 is regulatory in nature.
They suggested that the expression of the genes
coding for lPNS, isopenicillin N epimerase and
deacetoxycephalosporin C synthetase was eliminated by
the mutation carried in N-2 (20-3.1).
A comparison of DNA sequence data for the cloned C.
acremonium lPNS gene with that for the same gene
isolated from strain N-2 (20-3.1) though does not
support this view. On the contrary strain N-2 (20-
3.1) would appear to produce an inactive lPNS enzyme
as the result of a single base pair change in the
I
coding region of the gene (Harford pers. com.).
Therefore cnp-7 would appear to correspond to a
mutation in the structural gene for lPNS. This
coupled with the complementation shown between cnp-7
and cnp-5 would suggest that cnp-5 may effect a gene
other than that coding for the lPNS enzyme itself.
The nature and role of the gene affected in the cnp-5
strain is not known, although speculations could be
made concerning either a role connected with
regulation or co-factor availability.
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Cross l2 also involved two strains which showed
phenotypic similarity in both being deficient in the
ring expansion of Pen N to yield DAOC. The results
of .this cross suggest that the mutations involved,
cnp-l and cnp-6 are not Lf.riked,with a considerable
number of CPC producing progeny being recovered on MM
supplemented with inositol plus thiabendazole.
Linkage between cnp-6 and the wild-type allele of ino-
~ being a possible explanation for the low recovery of
the CPC producing phenotype on MM. The mutations
impairing CPC biosynthesis in the parental strains
would, therefore, appear to be affecting different
genes whilst resulting in similar phenotypes. From
the information available it was not possible to draw
any conclusions as to the identity of the biochemical
functions affected in each of the two strains. It
would be of interest to determine whether or not
deacetoxycephalosporin. C synthetase. activity is
present in the st.raLns carrying cnp-l or cnp-6.
Felix et al (l98l) reported the isolation of a mutant
C. acremonium strain which overproduced Pen N
apparently as a result of the mislocation of this
enzyme in the cell such that when preparations of
permeabilized cells were assayed active enzyme was
present and able to convert exogenously supplied Pen N
into DAOC. This would provide one possibility as to
the types of mutations other than those affecting the
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structural- gene which could result in the phenotype
shown by the strains carrying cnp-l and cnp-6. Other
possibilities could involve a regulatory function or a
role concerned with co-factor availability for one or
both of the genes affected. Scheidegger et al (1984)
showed the close association of deacetoxycephalosporin
C synthetase and deacetoxycephalosporin C hydroxylase
activity during purification. The two enzyme
activities have recently been found to remain
associated in a ratio of 7 to 1 deacetoxycephalosporin
C synthetase to hydroxylase on purification with a
single monomeric protein of molecular weight 41,000
+/- 2,000 most probably appearing to be responsible
for both activities (Dotzlaf and Yeh 1987) giving
support to Scheidegger et al (1984) who suggested that
a single bifunctional enzyme existed. Dotzlaf and
Yeh (1987) comme,nt that the stoichiometry of the
conversion of Pen N into DAOC and DAC does not
eliminate the poss~bility that these stages may
involve the existence of enzyme bound intermediates.
Were this so it is possible that an explanation for
the role of the genes mutated in the strains carrying
cnp-l and cnp-6 might be related to the formation of
such intermediates.
Several of the crosses carried out yielded progeny
which were more difficult to purify than the colonies
normally isolated from fusion plates. Colonies
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resembling- putative haploid recombinants showed.
considerable heterogeneity which in many cases
persisted throughout several rounds of purification.
~his was particularly noticeable in the divergent
crosses 9 and 10 between strains from the 20-3.1 (N-2)
and 20-2.1 (C0728) lineages. The inclusion of
thiabendazole at low levels in the growth medium did
not appear to significantly increase the degree of
haploidisation occurring. Hamlyn (1982) reported the
occurrence of abnormal heterozygous colonies following
a fusion between two strains derived from the M8650
progenitor strain. These colonies were presumed to
be aneuploids and on transfer from a minimal to a
complete medium they produced sectors carrying one
particular auxotrophic requirement from one of the
parental strains. The presence of a translocation
which would result
\
in the only viable haploid
segregants able to be produced from the aneuploid
being auxotrophic was suggested as an explanation for
the stability of the aneuploids whilst on minimal
medium. The instability of progeny obtained from A.
nidulans crosses in which one of the parental strains
carried a non-recipricol translocation has also been
described. This mitotic non-conformity was observed
amongst progeny carrying the translocated chromosomal
segment as a duplication. These strains showed
slower growth compared to the parents and had a
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modified morphology. The loss of all or part of one
of the duplicated chromosomal segments resulted in the
production of sectors of growth approaching wild-type
with respect to growth rate and morphology, (Azevedo
and Roper 1970). Speculations could be made as to
the existence of differences in chromosomal
arrangement between strains derived from 20-3.1 (N-2)
and those derived from the 20-2.1 (C0728) lineage
which might act in a similar manner to produce the
heterozygous type of fusion products recovered from
crosses 9 and 10.- The data available does not
clearly implicate the involvement of any particular
linkage group in such an effect. For an
understanding of the reasons behind the occurrence of
the heterozygous colonies the inclusion of additional
genetic markers into the parental strains would be
necessary to allow a more detailed analysis of the
I
segregation of linkage groups in future crosses.
A number of progeny purified from crosses 9 and 10
were found to produce no detectable Pen N despite the
fact that the lowest titre parental strain always gave
a small though detectable activity against Sarcina
lutea ATCC 9341. Many of the progeny falling into
this group were isolated in group III i.e. those
purified from YEAjCasamino acids medium. This
phenomenon is also noticeable in other divergent
crosses, 5 and 6 for example, but not in the sister
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strain crosses 11 and 12. A skewness in B-lactam
titre distribution amongst progeny from crosses with a
tendency for the progeny mean titre to fall below the
parental mean titre was observed in a number of
crosses by Perez-Martinez (1984) and attributed to
epistatic interactions.
The data from the crosses described give little
consistent evidence for linkage between the genetic
markers segregating. Cases where two markers appeared
linked, for example leu-4 and his-2 in fusion 9 are
seen but the linkages are only apparent amongst
progeny selected under certain circumstances, and are
not supported when the data from all the crosses are
considered as a whole. These inconsistencies are
reminescent of some data obtained by Hamlyn (1982)
which showed aberrant linkage relationships amongst
of some crosses compared to the
\
acremonium linkage map. The possible
the progeny
established C.
operation of undefined selective pressures when
media directlyprogeny are recovered on selective
following fusion could explain the
towards the recovery of certain
apparent bias
selective advantage of progeny
allele over those carrying leu
phenotypes.
carrying the
A
+leu
has been described
previously (Perez-Martinez, 1984). Evidence for
linkage involving the cephalosporin C non-producing
markers was suggested in cases where unexpectedly high
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numbers of CPC producing progeny were recovered.
Cross 11 showed possible linkages of either cnp-5 with
orn-l or cnp-6 with met-13 but these are not totally
consistent with the results of fusions 9 and 10. The
strongest case for linkage is perhaps that for the
linkage of cnp-6 to the wild-type allele of the ino-2
marker already discussed for cross 12.
all cases the future establishment
However, in
of linkage
relationships between these markers would depend upon
determining a consistent pattern of behaviour for them
over a number of crosses.
CHAPTER 5
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General Discussion
Studies of the, genetics of the imperfect fungus ~
acremonium (Hamlyn and Ball 1979; Hamlyn 1982), began
with attempts to apply the parasexual methods which
had proved successful in A. nidulans (Pontecorvo and
Roper 1952; Roper 1952; Pontecorvo et al 1953; Roper
and Pritchard 1955; Pontecorvo 1952; Forbes 1959) and
~ chrysogenum (Pontecorvo and Sermonti 1953, 1954;
Sermonti 1954, 1956, 1957, 1961). The initial
difficul ty in achieving the formation of a hetero-
karyon stage was overcome by the use of protoplast
fusion and a method for parasexual genetic analysis in
c. acremonium was subsequently described (Hamlyn and
Ball 1979; Hamlyn 1982). In approximately 1% of
cases, protoplast fusion is followed by nuclear fusion
giving rise to a transient diploid stage. Two types
of progeny may then be recovered for analysis; haploid
recombinants arising after spontaneous haploidisation
which are isolated by plating fusion mixtures on a
range of selective media; and heterozygous colonies,
bel ieved to be aneuploid for one or more chromosomes
or even diploid in some cases which sector to yield
haploid recombinants. The use of this system for
parasexual analysis enabled the development of a
linkage map for c. acremonium (Hamlyn et al 1985).
Quantitative studies demonstrated the polygenic nature
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of CPC
respect
biosynthesis
to other
and allowed
markers, of
the location, with
effective factors
influencing antibiotic titre (Perez-Martinez 1984).
The work described here was aimed towards
developing the study of the· genetic basis of CPC
production towards a point at which information
concerning genes encoding key enzymes in the bio-
synthetic pathway could be obtained.
In the course of these studies it was observed that
the usual expectation that the product of an C.
acremonium protopla~t fusion cross is a transient
diploid which rapidly gives rise to haploid segregants
was not always fulfilled. The persistent
heterogeneity of many of the fusion products obtained
in two of the crosses (9 and 10) would question
whether the diploid or heterozygous phase is always as
transient as previously assumed. There have been
previous reports of rare 'stable heterozygotes' which
have been account~d for by proposing that a
chromosomal abnormality present in one of the parental
strains concerned, resulted in the unusual stability
of an aneuploid stage under the particular selective
conditions employed (Hamlyn 1982, Perez-Martinez
1984). As the pool of information concerning the
parasexual genetics of C. acremonium is expanded it
may be anticipated that the genetic basis underlying
both the transient nature of the diploid .stage and the
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observed exceptions to this will be revealed. The
possibility of constructing stable strains aneuploid
for linkage groups carrying genes either encoding rate
.Ldrni.tLnq enzymes in CPC biosynthesis or responsible
for regulatory effects along with .po s s i.b Le
implications for strain improvement might also be
envisaged but would require the mapping of genes
implicated in the biosynthesis pathway to linkage
groups.
A number of strains of C. acremonium carrying
mutations resulting in blocks of CPC biosynthesis
isolated in different laboratories were available for
use in mapping studies. Complementation and the
restoration of CPC production has been demonstrated
between two such strains (Perez-Martinez 1984). The
strains available had been derived from divergent
lineages of C. acremonium raised titre
--- ,~~~~~~
strains.
Therefore the use of these in mapping studies was
considered to be limited as in any cross the diversity
of the genetic backgrounds of the two parents might be
anticipated to mask to some degree the segregation of
the genes of particular interest, by either pleio -
tropic or more direct regulatory effects. The
existence of barriers to recombination between strains
as a result of the introduction of changes in
chromosome structure during the different programmes
of strain improvement was also a potential problem.
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A closely related group of C. acremonium strains
carrying mutations affecting CPC biosynthesis were
therefore isolated and characterised following the
U.V. mutagenesis of a raised titre strain. After the
induction of selectable markers to facilitate proto-
plast fusion, these strains were used alongside those
already discussed in genetic studies. eomple-
mentation tests were performed between pairs of
blocked strains. It is of interest that complemen-
tation was shown by two strains which both carried
mutations (cnp-l and cnp-6), resulting in apparently
identical phenotypes i.e. in a loss of the ability to
produce DAoe from Pen N. This would suggest that
more than one gene function may be required for this
particular step in CPC biosynthesis.
Complementation was also shown between the cnp-5
and cnp-7 mutations which both appeared to result in
\
an inability to convert the ACV tripeptide precursor
of CPC into isopenicillin N.
As the linkage map for C. acremonium was
established using marked strains of the M8650 low
titre lineage, information regarding the linkage group
location of the mutations present in the blocked
strains could not be derived from the crosses designed
to assess complementation. However, linkage
relationships between these mutations and the markers
introduced to allow the selection of fus ion products
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were studied and evidence for the linkage of cnp-6 and
ino-2 was obtained.
The future mapping of the mutations carried by the
blqcked strains would require the use of a CPC
producing strain, closely related to and preferably
derived from the same progenitor strain as the blocked
mutant strains. This strain would ideally carry a
sufficient number of markers to allow the segregation
of each C. acremonium linkage group to be followed and
would, therefore, act as a master strain for the
genetic analysis of antibiotic production in this
organism. Data obtained from mapping studies would
be expected not only to yield information concerning
structural genes involved in the CPC biosynthetic
pathway, but also to allow the location of genes
playing regulatory roles. A knowledge of the
location of such genes with respect to other genetic
markers, could be envisaged to be of use as the
techniques of molec~lar biology are applied to C.
acremonium with a view to the cloning and modification
of genes underlying CPC biosynthesis for which a
readily applicable selection system might not
necessarily be available.
Crosses aimed at relating markers present in a C.
acremonium raised titre master strain to those present
in a number of M8560 strains would be of use in
relating information concerning the location of genes
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implicated in CPC biosynthesis to the C. acremonium
linkage map and could reveal differences in chromo-
somal arrangement induced in the raised titre lineage
during strain improvement.
The contribution of classical genetic studies to
the industrial exploitation of organisms such as C.
acremonium would appear to be somewhat limited. The
induction of the necessary markers and the
construction of a sufficiently detailed linkage map to
allow a truly planned breeding strategy to be used in
strain improvement _would be extremely time consuming
in comparison to the increase in antibiotic titre
already achieved through programmes of mutation and
selection. However, the recovery, following proto-
plast fusion in C. acremonium, of progeny combining
the improved antibiotic titre of one parent strain
with the good sporulation characteristics of the other
\
parent has been reported (Hamlyn and Ball 1979) and
Van der Beek et al (1986) described the use of proto-
plast fusion in P. chrysogenum to improve the charac-
teristics of strains used in penicillin production.
In the latter case, the genetic markers introduced in
order to allow the selection of fusion products did
.
not, in themselves, affect the antibiotic titre of the
parental production strains. The development of
selection systems for ~ acremonium which would avoid
the introduction of possibly deleterious mutations
-206-
whilst allowing strains of industrial use to be
crossed, would therefore be desirable.
The recent development of transformation systems
and cloning vectors for use with C. acremonium
(Queener et al 1984), Penalva et al 1986), the
isolation and sequencing of the gene encoding IPNS and
the recent isolation of a gene encoding expendase and
hydroxylase activities from this organism (Samson et
al 1985, Harford et al ~986, Ignolia et al 1987) has
opened the way for a more direct study of the genetic
basis of CPC biosynthesis than has hitherto been
possible. Such studies may be expected to have
considerable implications for the development of
strains with improved CPC production characteristics,
in allowing the investigation of the control of the
expression of key genes in CPC biosynthesis and the
effect on CPC production of adjusting the copy number
of such genes. The future possibilities for the
genetic manipulation of CPC biosynthesis
therefore appear to be promising.
would
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APPENDIX I
Mapping Crosses with Strains From the M8650 lineage.
A number of protoplast fusion crosses were carried
out with the aim of providing additional information
on the linkage relationships between certain markers
present in the M8650 derived strains which had been
used in the construction of the C. acremonium linkage
map.
Crosses Al and A2 (Table 1) were repeats of crosses
originally carried out by Hamlyn (1982), the results
of which had in part conflicted with those expected
given the linkage relationships between the markers
involved established from other crosses. Hamlyn' s
data for cross Al showed a lack of recovery of progeny
carrying the ben-l allele from selective plates
supplemented with leucine thus questioning the
established linkage between ane-5 and ben-I. For
cross A2 the data showed the apparent linkage of the
ben-I, Lno=L, red-l and pyt-l markers. When the
crosses were repeated the data (Table 2) did not
display the same trends. Progeny carrying the ben-l
allele we re "recovered from cross AI, although there
was a lack of progeny carrying the ane- 5 allele.
The leaky nature of the ane-5 allele, however, did
pose problems in the identification of progeny
-235-
TABLE 1 Crosses between strains of the M8650
lineage.
CROSS PARENTAL STRAINS
Al 20-1.4 azu-l arg-l mor-l leu-l red-l pyt-l
ben-l
20-1.8 ane-5 ino-l
A2 20-1.16 red-l arg-2 pyt-l
20-1.20 leu-l ino-l ben-l mor-l
A3 20-1.8 ane-5 ino-l
20-1.13 lys-l phe-l
A4 20-1.4 azu-l arg-l mor-l leu-l red-l pyt-l
ben-l
20-1.13 lys-l phe-l
\
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Table 2 Pairwise analysis tables for crosses Al and A2
Cross Al
From MM supplemented with arginine plus aneurin
ane azu ben red
+ + + +
+ (12) 5 10 ( 7 ) 8 (9 ) 4 (13 )
arg
14 ( 1) ( 8 ) 7 ( 3 ) 12 ( 2 ) 13
+ ( 14) 12 ( 10) 16 ( 3 ) 23
ane
4 ( 2) 1 ( 5 ) 3 ( 3 )
+ 7 ( 11) 3 (15 )
azu
( 4 ) 10 (3 ) 11
+ 1 (10 )
ben
( 5 ) (6 )
From MM supplemented with leucine plus inositol
ino azu ben red
+ + + +
+ ( 0) 2 1 ( 1) 2 ( 0) 2 ( 0 )
leu
0 ( 0 ) (0 ) 0 ( 0) 0 ( 0 ) 0
+ ( 0) 0 (0 ) 0 ( 0) 0
ino
1 ( 1) 2 ( 0 ) 2 ( 0)
+ 1 ( 0 ) 1 (0 )
azu
( 1) 0 ( 1) 0
+ 2 (0 )
ben
(0 ) 0
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Table 2 Continued
From MM supplemented with leucine plus aneurin
ane azu ben red pyt
+ + + + +
+ ( 7 ) 0 5 (2 ) 4 ( 3 ) 2 ( 5 ) 6 ( 1)
leu
10 (0 ) ( 5 ) 5 ( 2 ) 8 ( 1 ) 9 ( 3 ) 7
+ (10) 7 ( 6 ) 11 ( 3 ) 14 (9 ) 8
ane
0 ( 0 ) (0 ) 0 0 ( 0 ) 0 ( 0 )
+ 4 ( 6 ) 3 ( 7 ) 6 ( 4 )
azu
(2 ) 5 (0 ) 7 ( 3 ) 4
+ 1 ( 5 ) 4 ( 2 )
ben
( 2 ) 9 ( 5 ) 6
From MM supplemented with arginine plus inositol
ina azu ben red
+ + + +
+ ( 1) 4 4 .( 1) 0 ( 5 ) 5 ( 0 )
arg
2 (2 ) ( 1) 3 ( 1) 3 (2 ) ·2
+ ( 1) 2 ( 1) 2 (1) 2
ina
4 (2 ) 0 ( 6 ) 6 ( 0)
+ 0 ( 5 ) 5 ( 0 )
azu
( 1) 3 ( 2 ) 2
+ 0 ( 1)
ben
( 7 ) 1
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Table 2 Continued
Cross A2
From MM supplemented with inositol
pyt ben mer red
+ + + +
+ ( 2 ) 15 12 ( 5) 15 ( 2) ( 1) 16
ino
16 (6 ) (6 ) 16 ( 7·) 15 21 ( 1)
+ (2 ) 15 ( 1) 17 16· ( 2 )
pyt
15 ( 6) 21 ( 0) (6 ) 15
+ ~6 ( 2 ) ( 6 ) 12
ben
(6 ) 15 16 ( 5)
+ ( 7 ) 15
mer
15 ( 2)
From MM supplemented with leucine
pyt ben mer red
+ + + +
+ ( 1) 18 16 ( 3 ) 17 ( 2 ) ( 1) 18
leu
5 ( 1) ( 1) 5 (2 ) 4 0 ( 6)
+ ( 1) 5 ( 1) 5 0 ( 6)
pyt
16 (.3 ) 18 ( 1) ( 1) 18
+ 15 ( 2 ) ( 0) 17
ben
(4 ) 4 1 ( 7 )
+ ( 1) 18
mer
0 (6 )
-239-
carrying it and so could be an explanation for this
observation. The results for cross A2 (Table 2)
showed the ben-l and ino-l markers to recombine
freely. Recombination between ane-5 and ino-l
appeared limited, again this was possibly due to a
bias against the identification of progeny carrying
the ane-5 allele. The frequency of recombination
between ino-l and red-Ion linkage group III
calculated from the data shown here is 15.8% which is
in the order of the figure of 12.9% determined by
Perez-Martinez (198~).
of linkage was apparent.
Two crosses, A3 and A4 in Table 1 were carried out
No other consistent evidence
with a view to positioning the phe-l marker on the C.
acremonium linkage map. Previous work (Perez-
Martinez 1984) had shown some indication of the
linkage of phe-l to lys-l on linkage group VI.
However, the evidence was not conclusive and a ,cross
between strain 20-1.4 (azu-l arg-l met-l leu-l ben-l
pyt-l ben-I) and 20-1.13 (lys-l phe-l) had failed
to demonstrate linkage between the azu-l marker,
previously mapped to linkage group VI and phe-l. The
results obtained here (Table 3) again
demonstrated that phe-l does not map onto linkage
groups I, II~ III, V, VII or VIII. The linkage of
phe-l and lys-l on group VI was again also a
possibility but recombination between phe-l and azu-l
.;..240-
Table 3 Pairwise analysis tables for crosses A3 and A4.
Cross A3
From MM Supplemented with aneurine plus lysine
lys
+
+ 9 8
ane
5 0
From MM Supplemented with aneurine
phe
+
+ 16 2
ane
17 2
No progeny were recovered from MM supplemented with inositol
plus lysine or inositol plus phenylalanine
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Table 3 Continued
Cross A4
From MM supplemented with arginine plus lysine
lys azu pyt ben red moi
+ + + + + +
+ ( 7) 1 1 (7 ) 4 (4) 2 (6 ) 5 (3) 7 (1)
arg
7 ( 0) ( 0) 7 (4) 3 (2 ) 5 (4) 3 (3) 4
+ (0) 14 (7 ) 7 (3) 11 (8 ) 6 (9 ) 5
lys
1 ( 0) 1 ( 0) 1 ( 0) 1 (0 ) 1 ( 0)
+ 1 ( 0) 1 (0 ) 1 ( 0) 1 ( 0)
azu
(7 ) 7 (3) 11 (8 ) 6 (9 ) 5
+ 4 (4) 6 (2) 6 (2)
pyt
(0) 7 (3) 4 (4) 3
+ 4 (0 ) 3 ( 1)
ben
(5 ) 6 (7 ) 4
+ 7 (2)
red
(3) 3
Cross A4
From MM supplemented with arginine plus phenylalanine
phe az~ pyt ben red mor
+ + + + + +
+ (9 ) 3 0 (12) 6 ( 6) 7 (5 ) 8 (4) 12 ( 0)
arg
2 (1 ) ( 0) 3 (2) 1 (2) 1 (2) 1 (1) 2
+ ( 0) 11 (5 ) 6 (6 ) 5 (6 ) 5 (9 ) 2
phe
0 (4) 3 (1) 3 (1) 4 ( 0) 4 (0 )
+ 0 ( 0) 0 (0 ) 0 ( 0) 0 (0 )
azu
(8 ) 7 (9 ) 6 (10) 5 (13 ) 2
+ 5' (3) 7 (1) 7 (1)
pyt
3(4) (3) 4 (6 ) 1
+ 6 (3) 8 (1)
ben
(4) 2 (5 ) 1
+ 9 (1)
red 4 1
- 241b -
Table 3 Continued
From MM supplemented with leucine plus phenylalanine
phe azu ben red
+ + + +
+ (6) 2 0 (8) 3 (5) 5 (3)
leu
4 (2) (0) 6 (3) 3 (5 )
+ (0) 10 (3) 7 (6) 4
phe
0 (4) 3 (1) 4 (0)
+ 0 (0) 0 (0)
azu (6) 8 (10) 4
+ 5 (1)
ben (5 ) 3
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was detected amongst the progeny selected on media
supplemented with either arginine plus phenylalanine
or leucine plus phenylalanine. The analysis of the
segregation of the phe-l marker in further crosses
would then be necessary in order to position this
marker on the ~ acremonium M8650 linkage map.
APPENDIX II
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APPENDIX II
Antibiotics titres of progeny recovered from Cross 9.
The distribution of titres amongst the separate groups
(I, II and III) of progeny recovered.
-244-
A. Progeny recovered on MM + leucine
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B.Progeny recovered on MM + histidine
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APPENDIX III
Antibiotic titres of progeny recovered from Cross 10.
The distribution of titres amongst the separate groups
(I, II and III) of progeny recovered.
Progeny
group
Progeny
group
-247-
A. Progeny recovered on MM + leucine
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B. Progeny recovered on NM -to hit;tidine
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Appendix IV
Allele Symbols
leu requirement for leucine
arg
met
ade
cys
ino
his
orn
s
nic
~
phe
red
!!lQf:..
azu
tbz
pyt
ben
£!!E_
II arginine
" methionine
" adenine
" cysteine
" inositol
" histidine
" ornithine
" reduced/organic sulphur
" nicotinic acid
" aneurin
" phenylalanine
produces red pigmentation
morphological marker
resistance to 6-azauracil
resistanc~ to thiabendazole
resistance to pyrithiamine
resistance to benomyl
impaired cephalosporin C biosynthesis
